Congressi e conferenze
Comunicazioni orali e poster
Trends in cancer incidence and mortality in Italy, 2013-2017
Perotti V, Tittarelli A, Contiero P, Maso LD, Pesce MT, Zarcone M, Gili A, Mazzucco W, Stracci F, Crocetti E, Fabiano S; AIRTUM Working Group. Cancer Epidemiol. 2025 Jun 3;97:102855. doi: 10.1016/j.canep.2025.102855. Abstract Cancer incidence and mortality trends...
Excision margins and prognosis in cutaneous melanoma: retrospective population-based cohort study
Buja A, Rugge M, Trevisiol C, Zanovello A, Dall'Olmo L, Zorzi M, Vecchiato A, Del Fiore P, Paiola M, Rossi CR, Mocellin S. BJS Open. 2025 May 7;9(3):zraf042. doi: 10.1093/bjsopen/zraf042. Abstract Background: The impact of surgical excision margin size on the survival...
Patterns of Comorbidities in Lung Cancer Patients and Survival
Buja A, Di Pumpo M, Rugge M, Zorzi M, Rea F, Pantaleo I, Scroccaro G, Conte P, Rigon L, Arcara G, Pasello G, Guarneri V; Rete Oncologica Veneta and Periplo Foundation. Cancers (Basel). 2025 May 6;17(9):1577. doi: 10.3390/cancers17091577. Abstract Introduction:...
A population-based estimation of breast cancer recurrence in northeast Italy with administrative healthcare databases
Giudici F, Toffolutti F, Guzzinati S, Schettini F, Bortul M, Francisci S, Zorzi M, De Vidi S, Pierannunzio D, Dal Maso L. Breast. 2025 May 1;82:104487. doi: 10.1016/j.breast.2025.104487. Abstract Background/aim: Information on the long-term frequency of recurrence is...
Cancer and Pregnancy: Update of Estimates in Italy by Linking Data from Cancer Registries and Hospital Discharge Records
Pierannunzio D, Maraschini A, Lopez T, Donati S, Corsi Decenti E, Ballotari P, Bella F, Bianconi F, Bidoli E, Bruni R, Cirilli C, De Vincenzo RP, Fantaci G, Furgiuele G, Iacovacci S, Ippolito A, Mangone L, Mantovani W, Merlo E, Mian M, Mazzucco W, Pesce MT, Sampietro...
Completion of nodal dissection in cutaneous melanoma with metastatic sentinel nodes: Prognostic impact in a population-based cohort study
Buja A, Rugge M, Trevisiol C, Zanovello A, Mazza M, Dall'Olmo L, Zorzi M, Vecchiato A, Del Fiore P, Rossi CR, Mocellin S. World J Surg Oncol. 2025 Mar 29;23(1):111. doi: 10.1186/s12957-025-03762-w. Abstract Background: In primary cutaneous melanoma (CM) with...
A real-world direct cost associated with a 4-year postdiagnosis follow-up in a population-based cohort of patients with melanoma by clinical-pathological characteristics
Buja A, Rugge M, Formaro CM, Grotto G, Cozzolino C, Stefano A, Zorzi M, Vecchiato A, Del Fiore P, Tropea S, Trevisiol C, Rossi CR, Mocellin S. Melanoma Res. 2025 Mar 28. doi: 10.1097/CMR.0000000000001033. Abstract In times of limited resources, data on the costs of...
Mapping the national health information systems by the cancer registry perspective: early findings from the survey
Lopez T; Francisci S; Cacciani L; Andreotti A; DeSchutter H; Martos Jiménez C; Nygård M; Rodon Navarro E; Guzzinati S. 49th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL) Porto, 27-30 maggio 2025 Abstract...
Incidence, treatment pathway and survival of central nervous system tumors by histotype in the Veneto region, Italy
Andreotti A; Ferroni E; Lombardi G; Guzzinati S; Zorzi M. 49th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL) Porto, 27-30 maggio 2025 Abstract Objectives: The aim of our study was to evaluate incidence,...
Survival in adolescents and young adults with cancer compared with children and adults in Europe: a Eurocare-6 study
Trama A; Rossi S; Cerza F; Didoné F; Botta L and Guzzinati S per the EUROCARE6 WG. 49th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL) Porto, 27-30 maggio 2025 Abstract Objectives: In Europe, cancer survival...
Epidemiological causal models and their generalizabilty: a use case to study long-term effects in young cancer survivors
Bernasconi A, Zanga A, Trama A, Guzzinati S, Andreotti A, Ada WG. and ROSANNA validation WG. 49th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL) Porto, 27-30 maggio 2025 Abstract Objectives: Thanks to their...
Risk of metastatic recurrence in Italian women with breast cancer using population-based data: a modelling approach
Giudici F, De Vidi S, Guzzinati S, Toffolutti F, Dal Maso L, AIRTUM WG. 49th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL) Porto, 27-30 maggio 2025 Abstract Objectives: Information on cancer progression and...
Causalità e generalizzabilità dei modelli epidemiologici: utopia o realtà? Parliamone insieme!
A. Bernasconi, A. Zanga, A. Andreotti Ancillary meeting del XLIX – Congresso dell'Associazione Italiana di Epidemiologia 2025 Salerno, 9 Aprile 2025 Abstract Questo ancillary meeting vuole proporre una discussione metodologica (e non solo) sull’utilizzo di strumenti...
Trasparenza e trasportabilità dei modelli epidemiologici: il ruolo delle variabilità geografiche nel follow-up dei pazienti oncologici
Alice Bernasconi, Alessio Zanga, Ettore Bidoli, Luigino Dal Maso, Fabiola Giudici, Federica Toffolutti, Rosalba Amodio, Walter Mazzucco, Maurizio Zarcone, Rossella Bruni, Danila Bruno, Vanna Burgio, Francesco Cuccaro, Cinzia Tanzarella, Giulia Bertini, Adele...
Nuovo report sui tumori infantili e adolescenziali in Veneto
E’ scaricabile nella sezione Pubblicazioni/Monografie/Per età del sito web del Registro Tumori del Veneto il nuovo Report sui tumori nei bambini (0-14 anni) e negli adolescenti (15-19 anni) nella nostra Regione. Sono presentati i tumori più frequenti per fascia di età...
REPORT MESOTELIOMI. DICEMBRE 2024
REPORT_MESOTELIOMI_2024.PDF
E’ disponibile un aggiornamento dell’European Cancer Information System (ECIS) contenente i dati aggiornati dei tumori in Europa provenienti dai registri tumori
L’European Cancer Information System (ECIS) presenta i più recenti indicatori oncologici calcolati dai dati dei registri tumori europei di popolazione. Gestito dal Joint Research Centre (JRC), ECIS consente di esplorare i modelli geografici e le tendenze temporali...
Pubblicate le stime di incidenza al 2024
Sono pubblicate le stime dei casi incidenti in Veneto nel 2024 per le principali sedi tumorali. Le stime sonodisponibili per il totale della Regione e per le singole Aziende ULSS. I dati sono scaricabili dalla home delsito.
Il sito del Registro Tumori del Veneto si rinnova
Il sito web del Registro tumori del Veneto è stato riprogettato e affinato in conformità alle best practicespromulgate dall’Agenzia per l’Italia Digitale (AgID). Con l’occasione sono state anche aggiunte delle nuovesezioni e sono stati organizzati i contenuti in modo...
Towards a better registration of neuroendocrine neoplasms: The results of the Italian retrospective population-based study
Trama A, Cuccaro F, Damiani D, Bernasconi A, Panzuto F, Fazio N, Carone S, Burgio Lo Monaco MG, Bruni R, Caldarella A, Roselli A, Cortini B, Amodio R, Mazzucco W, Leite S, Lupi C, Baracco M, Carpin E, Dal Cin A, Fiore A, Memo L, Guzzinati S, Torrisi AAM, Torrisi A,...
NON-SMALL-CELL LUNG CANCER: Real-World Population-Based Cohorts’ Study
Buja A, Rugge M, Bortolami A, Zorzi M, Rea F, Zanovello A, Scroccaro G, Conte P, Pasello G, Guarneri V, On Behalf Of Rete Oncologica Veneta, Periplo Foundation. Cancers (Basel). 2025 Feb 14;17(4):648. doi: 10.3390/cancers17040648. Abstract Introduction: This...
Cost profiles of cancer patients at the end of life: Estimates from the EPICOST-study
Guzzinati S, Andreotti A, Lopez T, Gori S, Gagliani A, Mallone S, Pierannunzio D, Tavilla A, Buja A, Zorzi M, Francisci S. PLoS One. 2025 Feb 14;20(2):e0318849. doi: 10.1371/journal.pone.0318849. eCollection 2025. Abstract Objectives: The study aims to analyze care...
International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study
Botta L, Didonè F, Lopez-Cortes A, Nieto AC, Desandes E, Hjalgrim LL, Jakab Z, Stiller CA, Zeller B, Gatta G, Pritchard-Jones K; BENCHISTA Project Working Group. Lancet Child Adolesc Health. 2025 Feb;9(2):89-99. doi: 10.1016/S2352-4642(24)00302-X. Abstract Background:...
Predizione dei recettori biologici dai referti di patologia mammaria mediante Text Mining e Machine Learning
Andreotti Alessandra, Guzzinati Stefano, Baracco Maddalena, Baracco Susanna, Bovo Emanuela, Carpin Eva, Dal Cin Antonella, Fiore Anna Rita, Greco Alessandra, Memo Laura, Monetti Daniele, Rizzato Silvia, Stocco Carmen Fiorella, Stocco Jessica Elisabeth, Zamberlan Sara,...
Biological receptor prediction from breast pathology reports using Text Mining and Machine Learning methodologies
Andreotti Alessandra, Baracco Maddalena, Carpin Eva, Dal Cin Antonella, Fiore Anna Rita, Guzzinati Stefano, Memo Laura, Zorzi Manuel. 48th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Lausanne, 15 - 17 May...
Health care costs of cancer patients at the end of life: estimates from the EPICOST-2 study
Silvia Francisci, Alessandra Andreotti, Alberto Gagliani, Silvia Gori, Stefano Guzzinati, Sandra Mallone, Daniela Pierannunzio, Andrea Tavilla 48th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Lausanne, 15 -...
Predizione dei recettori biologici dai referti di patologia mammaria mediante Text Mining e Machine Learning
Alessandra Andreotti, Maddalena Baracco, Susanna Baracco, Eva Carpin, Antonella Dal Cin, Anna Rita Fiore, Stefano Guzzinati, Laura Memo, Carmen Fiorella Stocco, Manuel Zorzi XXIV RIUNIONE SCIENTIFICA AIRTUM Caserta, 8-10 Maggio 2024 Abstract OBIETTIVI Nei referti di...
Incidenza del tumore alla mammella in Veneto: differenze per area geografica di provenienza
Eliana Ferroni, Stefano Guzzinati, Alessandra Andreotti, Emanuela Bovo, Alessandra Greco, Jessica Elisabeth Stocco, Carmen Stocco, Susanna Baracco, Sara Zamberlan, Manuel Zorzi XXIV RIUNIONE SCIENTIFICA AIRTUM Caserta, 8-10 maggio 2024 Abstract OBIETTIVI Obiettivo...
Projecting cancer prevalence by phase of care: a methodological approach
Guzzinati S, Tursini F, Dal Maso L, Gigli A , Francisci S. 47th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Mont Saint-Michel, Normandy, 31 May - 2 June 2023 Abstract INTRODUCTION: In most developed...
Time trends of cancer incidence in young adults (20-49 years) in Italy. A population – based study, 2008-2017
AIRTUM Working Group1; Stracci F, Serraino D, Fusco M, Mazzucco W, Fabiano S, Tittarelli A, Perotti V, Dal Maso L, Zorzi M, Migliore E, Ferrante M, Gasparotti C, Ghisleni S, Cavallo R, Teresa Pesce M, Casella C, Ballotari P, Galasso R, Manzoni F, Spata E, Gentilini...
Prevalence and indicators of cure of Italian women with vulvar squamous cell carcinoma: A population-based study
Bucchi L, Giudici F, Toffolutti F, De Paoli A, Mancini S, Preti M, Gatta G, Ferretti S, Crocetti E, Fiore AR, Bidoli E, Caldarella A, Falcini F, Gili A, Cuccaro F, Gambino ML, Casella C, Cavallo R, Ferrante M, Migliore E, Carrozzi G, Musolino A, Mazzucco W, Gasparotti...
Pubblicati i dati di incidenza aggiornati al 2021
Gentile Visitatrice/Visitatore, il Registro Tumori del Veneto aggiorna i dati di registrazione della patologia oncologica della popolazione residente nella regione Veneto al 31 12 2021.
Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030
Guzzinati S, Toffolutti F, Francisci S, De Paoli A, Giudici F, De Angelis R, Demuru E, Botta L, Tavilla A, Gatta G, Capocaccia R, Zorzi M, Caldarella A, Bidoli E, Falcini F, Bruni R, Migliore E, Puppo A, Ferrante M, Gasparotti C, Gambino ML, Carrozzi G, Bianconi F, Musolino A, Cavallo R, Mazzucco W, Fusco M, Ballotari P, Sampietro G, Ferretti S, Mangone L, Mantovani W, Mian M, Cascone G, Manzoni F, Galasso R, Piras D, Pesce MT, Bella F, Seghini P, Fanetti AC, Pinna P, Serraino D, Rossi S, Dal Maso L; AIRTUM Working Group. ESMO Open. 2024 Jul;9(7):103635. doi: 10.1016/j.esmoop.2024.103635. Epub 2024 Jul 23.
Trends in colorectal cancer surgical resection rates during the screening era: a retrospective study in Italy
Zorzi M, Calciano L, Gennaro N, Memo L, Rizzato S, Stocco C, Urso EDL, Negro S, Spolverato G, Pucciarelli S, Sbaraglia M, Guzzinati S. BMJ Open Gastroenterol. 2024 Aug 5;11(1):e001434. doi: 10.1136/bmjgast-2024-001434.
Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study
Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadié M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, Sánchez MJ, De Angelis R; EUROCARE-6 Working Group. Lancet Oncol....
Cancer incidence in immigrants by geographical area of origin: data from the Veneto Tumour Registry, Northeastern Italy
Ferroni E, Guzzinati S, Andreotti A, Baracco S, Baracco M, Bovo E, Carpin E, Dal Cin A, Greco A, Fiore A, Memo L, Monetti D, Rizzato S, Stocco JE, Stocco C, Zamberlan S, Zorzi M. Front Oncol. 2024 May 28;14:1372271. doi: 10.3389/fonc.2024.1372271. eCollection 2024....
Cutaneous melanoma in adolescents and young adults
Buja A, Rugge M, Trevisiol C, Zanovello A, Brazzale AR, Zorzi M, Vecchiato A, Del Fiore P, Tropea S, Chiarion-Sileni V, Rossi CR, Mocellin S. J Eur Acad Dermatol Venereol. 2024 May 6. doi: 10.1111/jdv.20077. Online ahead of print. Abstract Background: Cutaneous...
Could the mitotic count improve personalized prognosis in melanoma patients?
Buja A, Rugge M, Cozzolino C, Dossi F, Zorzi M, Vecchiato A, de Luca G, Del Fiore P, Tropea S, dall'Olmo L, Rossi CR, Boccuzzo G, Mocellin S. PLoS One. 2024 Apr 16;19(4):e0302309. doi: 10.1371/journal.pone.0302309. Abstract A number of studies have indicated that the...
Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study
Curti S, Gallo M, Ferrante D, Bella F, Boschetti L, Casotto V, Ceppi M, Cervino D, Fazzo L, Fedeli U, Giorgi Rossi P, Giovannetti L, Girardi P, Lando C, Migliore E, Miligi L, Oddone E, Perlangeli V, Pernetti R, Piro S, Storchi C, Tumino R, Zona A, Zorzi M, Brandi G,...
Indicators of cure for women living after uterine and ovarian cancers: a population-based study
Giudici F, De Paoli A, Toffolutti F, Guzzinati S, Francisci S, Bucchi L, Gatta G, Demuru E, Mallone S, Cin AD, Caldarella A, Cuccaro F, Migliore E, Gambino ML, Ravaioli A, Puppo A, Ferrante M, Carrozzi G, Stracci F, Musolino A, Gasparotti C, Cavallo R, Mazzucco W,...
Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy
Dal Maso L, Toffolutti F, De Paoli A, Giudici F, Francisci S, Bucchi L, Zorzi M, Fusco M, Caldarella A, Rossi S, De Angelis R, Botta L, Ravaioli A, Casella C, Musolino A, Vitale MF, Mangone L, Fanetti AC, Carpin E, Burgio Lo Monaco MG, Migliore E, Gambino ML, Ferrante...
Cutaneous melanoma in older patients
Buja A, Rugge M, Trevisiol C, Zanovello A, Brazzale AR, Zorzi M, Vecchiato A, Del Fiore P, Tropea S, Rastrelli M, Rossi CR, Mocellin S. BMC Geriatr. 2024 Mar 6;24(1):232. doi: 10.1186/s12877-024-04806-8. Abstract Background: In industrialized countries, the aging...
Geographical and temporal differences in gastric and oesophageal cancer registration by subsite and morphology in Europe
Giusti F, Martos C, Bettio M, Negrão Carvalho R, Zorzi M, Guzzinati S, Rugge M. Front Oncol. 2024 Feb 20;14:1250107. doi: 10.3389/fonc.2024.1250107. eCollection 2024. Abstract Background: Gastric and oesophageal cancers pose a serious public health concern. In 2020 a...
Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps
Zorzi M, Battagello J, Amidei CB, Antonelli G, Germanà B, Valiante F, Benvenuti S, Tringali A, Bortoluzzi F, Cervellin E, Giacomin D, Meggiato T, Rizzotto ER, Fregonese D, Dinca M, Baldassarre G, Scalon P, Pantalena M, Milan L, Bulighin G, Di Piramo D, Azzurro M,...
Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy
Gori S, Frayle H, Pagan A, Soldà M, Romagnolo C, Insacco E, Laurino L, Matteucci M, Sordi G, Busato E, Zorzi M, Maggino T, Del Mistro A; CIN2 study Working Group. Fam Med Community Health. 2024 Feb 2;12(Suppl 2):e002595. doi: 10.1136/fmch-2023-002595 AbstractCervical...
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S; EUROCARE-6 Working Group. Lancet Oncol. 2024 Jan...
Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019
Buja A, De Luca G, Zorzi M, Bovo E, Mocellin S, Trevisiol C, Bronte V, Guzzinati S, Rugge M. Front Public Health. 2024 Jan 8;11:1267534. doi: 10.3389/fpubh.2023.1267534. eCollection 2023. AbstractBackground: This observational study considers the sex-specific...
Nomina del nuovo referente scientifico del Registro Tumori del Veneto
Con Decreto n.167 del 17 novembre 2023 del Direttore Generale dell'Area Sanità e Sociale della Regione del Veneto, è stata nominata la Prof.ssa Marta Sbaraglia come nuovo referente scientifico del Registro Tumori del Veneto.Desideriamo ringraziare il Prof. Massimo...
Il Registro Tumori del Veneto è stato identificato Registro di rilevanza regionale e Centro di riferimento regionale del Veneto per il Registro Tumori Nazionale
Con DGR n.1628 del 22/12/2023, il Registro Tumori del Veneto è stato identificato quale Registro di rilevanza regionale e Centro di riferimento della Regione del Veneto per il Registro Tumori Nazionale, ai sensi del Decreto del Ministero della Salute del 01/08/2023 ...
The Veneto Tumour Registry has been identified as a Registry of regional relevance and as Referent centre for the Italian National Cancer Registry
The Veneto Tumour Registry has been identified as a Registry of regional relevance and as Referent centre for the Italian National Cancer Registry, instituted with the Decree of the Ministry of Health of 01/08/2023
The descriptive epidemiology of melanoma in Italy has changed – for the better
Bucchi L, Mancini S, Crocetti E, Dal Maso L, Baldacchini F, Vattiato R, Giuliani O, Ravaioli A, Zamagni F, Bella F, Bidoli E, Caldarella A, Candela G, Carone S, Carrozzi G, Cavallo R, Ferrante M, Ferretti S, Filiberti RA, Fusco M, Gatti L, Gili A, Iacovacci S, Magoni...
Pubblicati i dati di incidenza aggiornati al 2020
Gentile Visitatrice/Visitatore, il Registro Tumori del Veneto aggiorna i dati di registrazione della patologia oncologica della popolazione residente nella regione Veneto al 31 12 2020.
Incidence data for 2020 now available
Dear Visitor,the Veneto Tumour Registry updates the registration data of the oncological pathology of the population residing in the Veneto region to 31st December 2020.
Online the 2013-2017 incidence data of the RTV contained in vol. XII of Cancer Incidence in Five Continents (CI5), published by the International Agency for Research on Cancer (IARC) and the International Association of Cancer Registries (IACR)
See data at https://ci5.iarc.fr/ci5-xii/tables/summary Veneto CI5.pdfDownload
Online i dati di incidenza 2013-2017 del RTV contenuti nel vol. XII del Cancer Incidence in Five Continents (CI5), pubblicato dalla Agenzia Internazionale per la Ricerca sul Cancro (IARC) e dall’Associazione Internazionale dei Registri Tumori (IACR)
Dati disponibili al indirizzo https://ci5.iarc.fr/ci5-xii/tables/summary Vedi la scheda della Regione Veneto allegata. Veneto CI5.pdfDownload
Cost items in melanoma patients by clinical characteristics and time from diagnosis
Buja A, Cozzolino C, Zanovello A, Geppini R, Miatton A, Zorzi M, Manfredi M, Bovo E, Del Fiore P, Tropea S, dall'Olmo L, Rossi CR, Mocellin S, Rastrelli M, Rugge M. Front Oncol. 2023 Nov 8;13:1234931. doi: 10.3389/fonc.2023.1234931. eCollection 2023. Abstract...
Sex Differences in Soft Tissue Sarcoma: Incidence, Clinicopathological Profile, Survival, and Costs
Buja A, Rugge M, Tropea S, Cozzolino C, Formaro CM, Grotto G, Zorzi M, Vecchiato A, Del Fiore P, Brunello A, Sbaraglia M, Ferroni E, Rossi CR, Dei Tos AP, Mocellin S. J Womens Health (Larchmt). 2023 Nov;32(11):1257-1264. doi: 10.1089/jwh.2023.0019. Epub 2023 Oct 11....
Acceptability of deferring the start of cervical cancer screening to age 30 for women vaccinated against human papillomavirus
Martello G, Gori S, Frayle H, Franceschi S, Zorzi M, Del Mistro A. Prev Med Rep. 2023 Sep 22;36:102438. doi: 10.1016/j.pmedr.2023.102438. eCollection 2023 Dec. Abstract HPV vaccination of girls younger than 15 is very effective in reducing their risk of cervical...
Projecting cancer prevalence by phase of care: a methodological approach for health service planning
Francisci S, Tursini F, Dal Maso L, Gigli A, Guzzinati S. Front Oncol. 2023 Aug 30;13:1201464. doi: 10.3389/fonc.2023.1201464. eCollection 2023. Abstract Background: In most developed countries, the number of cancer survivors is expected to increase in the coming...
Nuovo report sul tumore del colon-retto in Veneto
E' pubblicato alla pagina https://www.registrotumoriveneto.it/it/pubblicazioni/monografie/per-sede il nuovo rapporto sull'epidemiologia del tumore del colon-retto nella nostra Regione. Il rapporto descrive i principali indicatori epidemiologici aggiornati all’anno...
Cancer and Pregnancy: Estimates in Italy from Record-Linkage Procedures between Cancer Registries and the Hospital Discharge Database.
Pierannunzio D, Maraschini A, Lopez T, Donati S, Amodio R, Bianconi F, Bruni R, Castaing M, Cirilli C, Fantaci G, Guarda L, Iacovacci S, Mangone L, Mazzoleni G, Mazzucco W, Melcarne A, Merlo E, Parazzini F, Peccatori FA, Rugge M, Sampietro G, Scambia G, Scarfone G,...
Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage
Lopez-Cortes A, Didonè F, Botta L, Hjalgrim LL, Jakab Z, Canete Nieto A, Stiller C, Zeller B, Gatta G, Pritchard-Jones K; BENCHISTA Project Working Group. Front Oncol. 2023 Aug 22;13:1232451. doi: 10.3389/fonc.2023.1232451. eCollection 2023. Abstract Introduction:...
Indicators of clinical performance in monitoring soft tissue sarcoma management: a population-based perspective.
Rugge M, Buja A, Tropea S, Girardi G, Cozzolino C, Zorzi M, Vecchiato A, Stefano A, Del Fiore P, Brunello A, Brazzale A, Sbaraglia M, Dei Tos AP, Baldo V, Benini P, Bortolami A, Rastrelli M, Dall'Olmo L, Rossi CR, Mocellin S. Front Med (Lausanne). 2023 Aug...
Pubblicati i dati di prevalenza al 01.01.2020
Il Registro Tumori del Veneto ha aggiornato i dati di prevalenza della patologia oncologica nella popolazione residente nella regione Veneto.Complessivamente, i veneti che hanno avuto una diagnosi di tumore e che sono vivi al 1 gennaio 2020 sono 310.545, poco più del...
Synchronous and metachronous multiple primary cancers in melanoma survivors: a gender perspective
Guzzinati S, Buja A, Grotto G, Zorzi M, Manfredi M, Bovo E, Del Fiore P, Tropea S, Dall'Olmo L, Rossi CR, Mocellin S, Rugge M. Front Public Health. 2023 Jun 16;11:1195458. doi: 10.3389/fpubh.2023.1195458. eCollection 2023. Abstract Background: Long-term survivors of...
Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries
Toffolutti F, Guzzinati S, De Paoli A, Francisci S, De Angelis R, Crocetti E, Botta L, Rossi S, Mallone S, Zorzi M, Manneschi G, Bidoli E, Ravaioli A, Cuccaro F, Migliore E, Puppo A, Ferrante M, Gasparotti C, Gambino M, Carrozzi G, Stracci F, Michiara M, Cavallo R,...
Epidemiology, pathological characteristics and survival of retroperitoneal soft‑tissue sarcomas compared with non‑retroperitoneal soft tissue sarcomas.
Buja A, Rugge M, Barillaro M, Miatton A, Tropea S, Cozzolino C, Zorzi M, Vecchiato A, Del Fiore P, Brunello A, Baldo V, Rossi CR, Mocellin S. Oncol Lett. 2023 May 26;26(1):301. doi: 10.3892/ol.2023.13887. eCollection 2023 Jul. Abstract Retroperitoneal soft-tissue...
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes
Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R; EUROCARE-6 Working Group. Front Oncol. 2023 Apr 24;13:1114701. doi: 10.3389/fonc.2023.1114701. eCollection 2023. Abstract Introduction: Comparable...
Trends in Net Survival from Vulvar Squamous Cell Carcinoma in Italy (1990-2015)
Mancini S, Bucchi L, Zamagni F, Baldacchini F, Crocetti E, Giuliani O, Ravaioli A, Vattiato R, Preti M, Tumino R, Ferretti S, Biggeri A, Ballotari P, Boschetti L, Brustolin A, Caldarella A, Cavallo R, Cirilli C, Citarella A, Contrino ML, Dal Maso L, Filiberti RA,...
Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study
Zorzi M, Antonelli G, Amidei CB, Battagello J, Germanà B, Valiante F, Benvenuti S, Tringali A, Bortoluzzi F, Cervellin E, Giacomin D, Meggiato T, Rosa-Rizzotto E, Fregonese D, Dinca M, Baldassarre G, Scalon P, Pantalena M, Ann Intern Med. 2023 Feb 21. doi:...
Machine learning to predict overall short-term mortality in cutaneous melanoma
Cozzolino C, Buja A, Rugge M, Miatton A, Zorzi M, Vecchiato A, Del Fiore P, Tropea S, Brazzale A, Damiani G, dall'Olmo L, Rossi CR, Mocellin S. Discov Oncol. 2023 Jan 31;14(1):13. doi: 10.1007/s12672-023-00622-5. AbstractBackground: Cutaneous malignant melanoma (CMM)...
The impact of the COVID-19 pandemic on Italian population-based cancer screening activities and test coverage: Results from national cross-sectional repeated surveys in 2020
Giorgi Rossi P, Carrozzi G, Falini P, Sampaolo L, Gorini G, Zorzi M, Armaroli P, Senore C, Sassoli de Bianchi P, Masocco M, Zappa M, Battisti F, Mantellini P. Elife. 2023 Feb 3;12:e81804. doi: 10.7554/eLife.81804. AbstractBackground: In Italy, regions have the mandate...
Overordering of tumor marker for outpatients revealed by performance indicators and the impact of a health policy intervention: An observational study using administrative records
Gion M, De Gobbi R, Zorzi M, Carretta G, Leonardi L, Guzzinati S, Trevisiol C, Cancian M, Cardinali G, Michieletto F, Dittadi R, Fabricio ASC, Rugge M, Russo F. Int J Biol Markers. 2023 Feb 28:3936155231154663. doi: 10.1177/03936155231154663. AbstractPurpose: The...
Nuovo report sul tumore della mammella nelle donne in Veneto
E' pubblicato alla pagina https://www.registrotumoriveneto.it/it/pubblicazioni/monografie/per-sede il nuovo rapporto sull'epidemiologia del tumore della mammella femminile nella nostra Regione. Il rapporto descrive i principali indicatori epidemiologici aggiornati...
Aggiornati i dati di sopravvivenza
Il Registro Tumori del Veneto ha aggiornato i dati di sopravvivenza dei soggetti con patologia oncologica residenti nella regione Veneto. E' presentata la sopravvivenza dei soggetti che hanno avuto una diagnosi di tumore nel periodo 2014-2016.I dati sono consultabili...
Renal cell carcinoma: the population, real world, and cost-of-illness
Buja A, De Luca G, Gatti M, Cozzolino C, Rugge M, Zorzi M, Gardi M, Sepulcri M, Bimbatti D, Baldo V, Maruzzo M, Basso U, Zagonel V. BMC Urol. 2022 Dec 19;22(1):206. doi: 10.1186/s12894-022-01160-y. AbstractBackground: The RCC treatment landscape has evolved...
Survival data updated
The Veneto Cancer Registry has updated the survival data of subjects with oncological pathology residing in the Veneto region.The survival of subjects diagnosed with cancer in the period 2014-2016 is presented.Data are available in the website at the page Survival.
Quality control on digital cancer registration
Guzzinati S, Battagello J, Bovo E, Baracco M, Baracco S, Carpin E, Dal Cin A, Fiore AR, Greco A, Martin G, Memo L, Monetti D, Rizzato S, Stocco C, Zamberlan S, Zorzi M, Rugge M. PLoS One. 2022 Dec 22;17(12):e0279415. doi: 10.1371/journal.pone.0279415. eCollection...
Trends in Liver Cancer Incidence and Survival in Italy by Histologic Type, 2003-2017
Mancini S, Bucchi L, Zamagni F, Guzzinati S, Dal Maso L, Rugge M, Bisceglia L, Serraino D, Casella C, Caldarella A, Falcini F, Musolino A, Carrozzi G, Rizzello RV, Mangone L, Mazzoleni G, Seghini P, Ferretti S, The Italian Cancer Registries' Collaborative Group....
[Update of survival of cancer patients in Italy: geographical comparisons and focus on patients with cancers targeted by screening programmes, childhood cancers, and smoking-associated cancers]
Ravaioli A, Crocetti E, Bucchi L, Guzzinati S, Casella C, Falcini F, Ferretti S, Giuliani O, Mancini S, Puppo A, Toffolutti F, Zamagni F, Zorzi M, Dal Maso L, Serraino D; Gruppo di lavoro Registri tumori italiani. Epidemiol Prev. 2022 Sep-Dec;46(5-6):356-366. doi:...
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3)
Girardi F, Matz M, Stiller C, You H, Marcos Gragera R, Valkov MY, Bulliard JL, De P, Morrison D, Wanner M, O'Brian DK, Saint-Jacques N, Coleman MP, Allemani C; CONCORD Working Group. Neuro Oncol. 2022 Nov 10:noac217. doi: 10.1093/neuonc/noac217. Abstract Background:...
Reply: Immortal time bias in a retrospective study examining colorectal cancer mortality according to adherence to colonoscopy
Zorzi M, Battagello J, Barbiellini Amidei C. Gut. 2022 Nov 4:gutjnl-2022-328905. doi: 10.1136/gutjnl-2022-328905. Pubmed https://pubmed.ncbi.nlm.nih.gov/36332970/
Impact of Microscopic Confirmation on Therapeutic Management of Pancreatic Cancer Patients: Lessons from an Italian Regional Tumor Registry
Fantin A, Gruppo M, De Simoni O, Lonardi S, Cristofori C, Morbin T, Peserico G, Grillo S, Masier A, Franco M, Pilati P, Guzzinati S, Zorzi M, Rugge M. Cancers (Basel). 2022 Oct 31;14(21):5372. doi: 10.3390/cancers14215372. Abstract Background: Incidence of pancreatic...
Cancer cost profiles: The Epicost estimation approach
Francisci S, Capodaglio G, Gigli A, Mollica C, Guzzinati S. Front Public Health. 2022 Sep 21;10:974505. doi: 10.3389/fpubh.2022.974505. eCollection 2022. Abstract Sustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses...
Impact of colorectal cancer screening on incidence, mortality and surgery rates: Evidences from programs based on the fecal immunochemical test in Italy.
Zorzi M, Urso EDL. Dig Liver Dis. 2022 Aug 20:S1590-8658(22)00633-8. doi: 10.1016/j.dld.2022.08.013. Online ahead of print. Abstract Fecal immunochemical tests (FIT) are among the most commonly used tests for colorectal cancer (CRC) screening programs worldwide....
Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective
Buja A, Rugge M, De Luca G, Zorzi M, Cozzolino C, Vecchiato A, Del Fiore P, Tropea S, Bortolami A, Benini P, Rossi CR, Mocellin S. Melanoma Res. 2022 Oct 1;32(5):353-359. doi: 10.1097/CMR.0000000000000841. Epub 2022 Jul 19. Abstract The prognosis of cutaneous...
Direct Costs of Care for Adults with Soft Tissue Sarcomas: A Population-Based Study
Rugge M, Buja A, Tropea S, Girardi G, Franzese LC, Cozzolino C, Zorzi M, Vecchiato A, Del Fiore P, Brunello A, Brazzale AR, Baldo V, Dei Tos AP, Rossi CR, Mocellin S. Cancers (Basel). 2022 Jun 24;14(13):3109. doi: 10.3390/cancers14133109. Abstract The clinical...
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study
Massari M, Spila Alegiani S, Morciano C, Spuri M, Marchione P, Felicetti P, Belleudi V, Poggi FR, Lazzeretti M, Ercolanoni M, Clagnan E, Bovo E, Trifirò G, Moretti U, Monaco G, Leoni O, Da Cas R, Petronzelli F, Tartaglia L, Mores N, Zanoni G, Rossi P, Samez S,...
Geographical differences in cancer prognosis: Italy, 2010-2018
Crocetti E, Ravaioli A, Serraino D, Guzzinati S, Bucchi L, Ferretti S, Toffolutti F, Zamagni F, Dal Maso L, Italian Cancer Registries WG 46th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Pamplona, 18-20...
New childhood cancer survival estimates in Italy
Crocetti E, Ravaioli A, Bucchi L, Guzzinati S, Casella C, Puppo A, Toffolutti F, Zamagni F, Dal Maso L, Italian Cancer Registries WG 46th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Pamplona, 18-20 may 2022...
New childhood cancer survival estimates in Italy
Crocetti E, Ravaioli A, Bucchi L, Guzzinati S, Casella C, Puppo A, Toffolutti F, Zamagni F, Dal Maso L, Italian Cancer Registries WG 46th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Pamplona, 18-20 may 2022...
Indicators of standard care for skin melanoma, computed by combining Cancer Registry information and administrative health data in Veneto. First results from the iPAAC 7.2 Pilot Study
Lillini R, Rugge M, Guzzinati S, Bonfarnuzzo S, Magri MC, Minicozzi P, Sant M. GRELL Ascension Meeting Luxembourg, 12-14 may 2021 Abstract Background and Aims:The pilot study 7.2 of iPAAC Joint Action evaluates the feasibility of linking Cancer Registry individual...
Geographical differences in cancer prognosis: Italy, 2010-2018
Crocetti E, Ravaioli A, Serraino D, Guzzinati S, Bucchi L, Ferretti S, Toffolutti F, Zamagni F, Dal Maso L, Italian Cancer Registries WG 46th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Pamplona, 18-20...
The Economic Impact of Rectal Cancer in Italy: results from the Epicost study
Francisci S, Capodaglio G, Dal Maso L, Gigli A, Guzzinati S, Lopez T, Mallone S, Pierannunzio D, Zorzi M. 46th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Pamplona, 18-20 may 2022
The Economic Impact of Rectal Cancer in Italy: results from the Epicost study
Francisci S, Capodaglio G, Dal Maso L, Gigli A, Guzzinati S, Lopez T, Mallone S, Pierannunzio D, Zorzi M. 46th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Pamplona, 18-20 may 2022
5-year survival after a diagnosis of cancers caused by tobacco smoking
Serraino D; Dal Maso L; Toffolutti F; Ravaioli A; Bucchi L; Guzzinati S; Falcini F; Mancini S; Zamagni F; Working Group, and Italian Cancer Registries. 46th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL)....
5-year survival after a diagnosis of cancers caused by tobacco smoking
Serraino D; Dal Maso L; Toffolutti F; Ravaioli A; Bucchi L; Guzzinati S; Falcini F; Mancini S; Zamagni F; Working Group, and Italian Cancer Registries. 46th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL)....
Performance of HPV E6/E7 mRNA Assay as Primary Screening Test. Results from the NTCC2 Trial
Giorgi Rossi P, Ronco G, Mancuso P, Carozzi F, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Venturelli F, Benevolo...
Nuovo report sui tumori infantili e adolescenziali in Veneto
E’ scaricabile nella sezione Pubblicazioni/Monografie/Per età del sito web del Registro Tumori del Veneto il nuovo Report sui tumori nei bambini (0-14 anni) e negli adolescenti (15-19 anni) nella nostra Regione. Sono presentati i tumori più frequenti per fascia di età...
Use of Routine Health Datasets to Assess the Appropriateness of Diagnostic Tests in the Follow-Up of Breast Cancer Patients: A Population-Based Study on 3930 Patients
Gion M, Cardinali G, Guzzinati S, Morandi P, Trevisiol C, Fabricio ASC, Rugge M, Zorzi M Risk Management and Healthcare Policy 2022, 15:1087-1100 Abstract Purpose: Clinical practice guidelines (CPGs) recommend against intensive follow-up in asymptomatic women with...
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.
Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard JL, Girardi F, Fowler C, Marcos-Gragera R, Bonaventure A, Saint-Jacques N, Minicozzi P, De P, Rodríguez-Barranco M, Larønningen S, Di Carlo V, Mägi M, Valkov M, Seppä K, Wyn Huws D, Coleman MP, Allemani...
Young immigrant women and cervical cancer screening: participation and lesions detected at the first screening round
Battagello J, Monetti D, Rizzato S, Rosano A, Stocco CF, Zamberlan S, Rugge M, Zorzi M. Epidemiol Prev 2022;46(3):47-54. Abstract OBJECTIVES: to evaluate if the country of origin affects participation and outcomes of cervical cancer screening. DESIGN: retrospective...
Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile.
Buja A, Rugge M, De Luca G, Bovo E, Zorzi M, De Toni C, Cozzolino C, Vecchiato A, Del Fiore P, Spina R, Cinquetti S, Baldo V, Rossi CR, Mocellin S. Curr Oncol. 2022 Mar 21;29(3):2165-2173. doi: 10.3390/curroncol29030175. Abstract Previous studies associated high-level...
Malignant Melanoma: Direct Costs by Clinical and Pathological Profile
Buja A, Rugge M, De Luca G, Zorzi M, De Toni C, Cozzolino C, Vecchiato A, Del Fiore P, Tropea S, Spina R, Baldo V, Rossi CR, Mocellin S. Dermatol Ther (Heidelb). 2022 Apr 15. doi: 10.1007/s13555-022-00715-z. Online ahead of print. Abstract Introduction: A number of...
Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses
Battisti F, Falini P, Gorini G, Sassoli de Bianchi P, Armaroli P, Giubilato P, Giorgi Rossi P, Zorzi M, Battagello J, Senore C, Zappa M, Mantellini P. Ann Ist Super Sanita. 2022 Jan-Mar;58(1):16-24. doi: 10.4415/ANN_22_01_03. Abstract Introduction: In Italy, regional...
Impact of Wide Local Excision on Melanoma Patient Survival: A Population-Based Study
Buja A, Rugge M, Damiani G, De Luca G, Zorzi M, Fusinato R, De Toni C, Vecchiato A, Del Fiore P, Falasco F, Spina R, Rossi CR, Mocellin S. Front Public Health. 2022 Mar 31;10:806934. doi: 10.3389/fpubh.2022.806934. eCollection 2022. Abstract Introduction: Promoting...
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
Zanelli S, Fiorio E, Zampiva I, Zacchi F, Borghesani G, Giontella E, Parolin V, Biondani P, Zuliani S, Dieci MV, Mioranza E, Zorzi M, Conti M, Gibellini D, Verlato G, Milella M. Ann Oncol. 2022 Mar 9:S0923-7534(22)00363-5. doi: 10.1016/j.annonc.2022.02.227. Online...
Late Mortality, Subsequent Malignant Neoplasms and Hospitalisations in Long-Term Survivors of Adolescent and Young Adult Hematological Cancers.
Trama A, Vener C, Lasalvia P, Bernasconi A; Ada Working Group. Front Oncol. 2022 Feb 25;12:823115. doi: 10.3389/fonc.2022.823115. eCollection 2022. Abstract Background: Increased success in the treatment of hematological cancers contributed to the increase of 5-year...
Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy
Rugge M, Zorzi M, Guzzinati S, Stocco C, Avossa F, Del Zotto S, Clagnan E, Bricca L, Dal Maso L, Serraino D. Tumori. 2022 Feb 8:3008916211073771. doi: 10.1177/03008916211073771. Online ahead of print. Abstract Introduction: This study assesses the risk of infection...
Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs
Buja A, Rugge M, Damiani G, Zorzi M, De Toni C, Vecchiato A, Del Fiore P, Spina R, Baldo V, Brazzale AR, Rossi CR, Mocellin S. J Womens Health (Larchmt). 2022 Jan 25. doi: 10.1089/jwh.2021.0223. Online ahead of print.PMID: 35076310 Abstract Introduction: This study...
Thyroidectomies in Italy: A population-based national analysis from 2001 to 2018
Pierannunzio D, Fedeli U, Francisci S, De Paoli A, Toffolutti F, Serraino D, Zoppini G, Borsatti E, Di Felice E, Falcini F, Ferretti S, Giorgi Rossi P, Gobitti C, Guzzinati S, Mattioli V, Mazzoleni G, Piffer S, Vaccarella S, Vicentini M, Zorzi M, Franceschi S, Elisei...
Impact of vaccination on the spread of SARS-CoV-2 infection in north-east Italy nursing homes. A propensity score and risk analysis
Pierobon S, Braggion M, Fedeli U, Nordio M, Basso C, Zorzi M. Age Ageing. 2022 Jan 6;51(1):afab224. doi: 10.1093/ageing/afab224. Abstract Background: In the Veneto Region, 421,000 coronavirus 2019 disease (COVID-19) cases and 11,000 deaths have been reported since 21...
HPV vaccination in women treated for Cervical Intraepithelial Neoplasia grade 2 or 3: evidence-based recommendation from the Multisociety Italian Guidelines for cervical cancer prevention
Venturelli F, the Multisociety Italian Guidelines for cervical cancer prevention Working Group. Eur J Gynaecol Oncol. 2021 vol. 42(5), 1039-1047. Abstract: Objective: Women treated for Cervical Intraepithelial Neoplasia (CIN) grade 2 or 3 are at increased risk of CIN...
Developing evidence-based Multisociety Italian Guidelines for cervical cancer prevention: rationale, methods, and development process.
Venturelli F, the Multisociety Italian Guidelines for cervical cancer prevention Working Group. Eur J Gynaecol Oncol. 2021 vol. 42(4), 634-642. Abstract: Objective: Cervical cancer prevention shows a variability across Italian Regions unjustified by available...
A prospective cohort study to identify biomarkers predicting the regression of grade 2 Cervical Intraepithelial Neoplasia. Study protocol
Del Mistro A, Frayle H, Gori S, Pagan A, Soldà M, Romagnolo C, Insacco E, Laurino L, Matteucci M, Busato E, Zorzi M, Maggino T, on behalf of the CIN2 study Working Group. European Journal of Gynaecological Oncology 2021 Volume 42 Issue 5 pp. 893-898. DOI:...
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)
Girardi F, Rous B, Stiller CA, Gatta G, Fersht N, Storm HH, Rodrigues JR, Herrmann C, Marcos-Gragera R, Peris-Bonet R, Valkov M, Weir HK, Woods RR, You H, Cueva PA, De P, Di Carlo V, Johannesen TB, Lima CA, Lynch CF, Coleman MP, Allemani C; CONCORD Working Group....
Quality management of cutaneous melanoma: impact on short-term outcomes and costs
Buja A, De Luca G, Zorzi M, Carpin E, Pinato C, Vecchiato A, Del Fiore P, Bortolami A, Tognazzo S, Falasco F, Saia M, Baldo V, Rugge M, Rossi CR, Mocellin S. Eur J Dermatol. 2021 Nov 17. doi: 10.1684/ejd.2021.4149. Online ahead of print. Abstract Promoting...
Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study
Buja A, Bardin A, Damiani G, Zorzi M, De Toni C, Fusinato R, Spina R, Vecchiato A, Del Fiore P, Mocellin S, Baldo V, Rugge M, Rossi CR. Front Oncol. 2021 Nov 16;11:737399. doi: 10.3389/fonc.2021.737399. eCollection 2021. Abstract Introduction: Among white people, the...
Indicators of standard care for skin melanoma, computed by combining Cancer Registry information and administrative health data in Veneto. First results from the iPAAC 7.2 Pilot Study
Lillini R, Rugge M, Guzzinati S, Bonfarnuzzo S, Magri MC, Minicozzi P, Sant M. GRELL Ascension Meeting Luxembourg, 12-14 may 2021 Abstract Background and Aims:The pilot study 7.2 of iPAAC Joint Action evaluates the feasibility of linking Cancer Registry individual...
Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort
Trama A, Tittarelli A, Barigelletti G, Botta L, Gatta G, Tagliabue G, Contiero P, Guzzinati S, Andreano A, Manneschi G, Falcini F, Castaing M, Filiberti RA, Gasparotti C, Cirilli C, Mazzucco W, Mangone L, Iacovacci S, Vitale MF, Stracci F, Piffer S, Tumino R, Carone...
Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012
Crocetti E, Mattioli V, Buzzoni C, Franceschi S, Serraino D, Vaccarella S, Ferretti S, Busco S, Fedeli U, Varvarà M, Falcini F, Zorzi M, Carrozzi G, Mazzucco W, Gasparotti C, Iacovacci S, Toffolutti F, Cavallo R, Stracci F, Russo AG, Caldarella A, Rosso S, Musolino A,...
SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study
Zorzi M, Guzzinati S, Avossa F, Fedeli U, Calcinotto A, Rugge M. Front Oncol. 2021 Oct 11;11:730131. doi: 10.3389/fonc.2021.730131. eCollection 2021. Abstract Aim: In a consecutive series of cancer patients tested for SARS-CoV-2 infection, this retrospective...
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study
Massari M, Spila-Alegiani S, Fabiani M, Belleudi V, Trifirò G, Kirchmayer U, Poggi FR, Mancuso P, Menniti-Ippolito F, Gini R, Bartolini C, Leoni O, Ercolanoni M, Da-Re F, Guzzinati S, Luxi N, Riccardo F, Giorgi-Rossi P. Vaccines (Basel). 2021 Jul 1;9(7):716. doi:...
United we win: Pushing for follow up after a positive faecal immunochemical test
Zorzi M, Rugge M. Dig Liver Dis. 2021 May 31:S1590-8658(21)00246-2. doi: 10.1016/j.dld.2021.05.003. Online ahead of print. Pubmed https://pubmed.ncbi.nlm.nih.gov/34083154/
Colorectal cancer incidence and mortality after negative fecal immunochemical tests by age 70: A prospective observational study
Zorzi M, Battagello J, Fiore AR, Memo L, Senore C, Rugge M. Int J Cancer. 2021 May 14. doi: 10.1002/ijc.33682. Online ahead of print. Abstract Limited endoscopy capacity usually represents the main barrier to the extension of screening to subjects older than 70,...
Prevalence data for 2020 now available
The Veneto Tumour Registry has updated the prevalence data of the oncological pathology of the population residing in the Veneto region. Overall, at 1st January 2020 the residents alive who had been diagnosed with cancer, were 310,545, more than 6% of the resident...
Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy
Alegiani SS, Crisafulli S, Rossi PG, Mancuso P, Salvarani C, Atzeni F, Gini R, Kirchmayer U, Belleudi V, Kurotschka PK, Leoni O, Ludergnani M, Ferroni E, Baracco S, Massari M, Trifirò G; ITA-COVID-19 Network. Rheumatology (Oxford). 2021 Apr 15:keab348. doi:...
A comprehensive assessment of the impact of a colorectal cancer screening program in a northern Italian area
Pancheri S, Pertile R, Armelao F, Rizzello RV, Piffer S, Zorzi M, Guzzinati S, Ferro A, Mantovani W, de Pretis G. Dig Liver Dis. 2021 Apr 11:S1590-8658(21)00130-4. doi: 10.1016/j.dld.2021.03.016. Online ahead of print. Abstract Background: The impact of a faecal...
Non-Small-Cell Lung Cancer: Real-World Cost Consequence Analysis
Buja A, Pasello G, De Luca G, Bortolami A, Zorzi M, Rea F, Pinato C, Dal Cin A, De Polo A, Schiavon M, Zuin A, Marchetti M, Scroccaro G, Baldo V, Rugge M, Guarneri V, Conte P. JCO Oncol Pract. 2021 Apr 7:OP2000863. doi: 10.1200/OP.20.00863. Online ahead of print....
Death for colorectal cancer among subjects who do not undergo a colonoscopy
We estimated whether non-compliance with colonoscopy after a positive Fecal Immunochemical Test (FIT) is associated with increased colorectal cancer incidence and mortality. We compared 23.400 subjects who did not undergo a colonoscopy after a positive FIT with 88.000...
Mancata esecuzione della colonscopia e rischio di morte: nuovo studio del Registro Tumori
I programmi di screening colo-rettale prevedono l’esecuzione di due esami: la ricerca del sangue occulto nelle feci seguito, in caso di positività, dalla colonscopia.Sono state studiate 23.400 persone che in Veneto, dopo un test positivo per il sangue occulto, non...
Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer
Zorzi M, Battagello J, Selby K, Capodaglio G, Baracco S, Rizzato S, Chinellato E, Guzzinati S, Rugge M. Gut. 2021 Mar 31:gutjnl-2020-322192. doi: 10.1136/gutjnl-2020-322192. Online ahead of print. Abstract Background: The risk of colorectal cancer (CRC) among subjects...
A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test
Del Mistro A, Battagello J, Weis L, Bressan V, Selle V, Ramigni M, Dal Zotto A, Maggiolo A, Gori S, Frayle H, Zappa M, Zorzi M, The Consensus Study Veneto Working Group. Viruses. 2021 Mar 16;13(3):486. doi: 10.3390/v13030486. Abstract Background: Efficacy for cervical...
More Favorable Short and Long-Term Outcomes for Screen-Detected Colorectal Cancer Patients
Spolverato G, Capelli G, Battagello J, Barina A, Nordio S, Finotti E, Mondi I, Da Lio C, Morpurgo E, Navarro JA, Ceccato F, Perin A, Pedrazzani C, Turri G, Zanus G, Campi M, Massani M, Di Giacomo A, Prando D, Agresta F, Pucciarelli S, Zorzi M, Rugge M. Front Oncol....
Adenoma detection by Endocuff-assisted versus standard colonoscopy in an organized screening program: the “ItaVision” Randomized Controlled Trial
Zorzi M, Hassan C, Battagello J, Antonelli G, Pantalena M, Bulighin G, Alicante S, Meggiato T, Rosa-Rizzotto E, Iacopini F, Luigiano C, Monica F, Arrigoni A, Germanà B, Valiante F, Mallardi B, Senore C, Grazzini G, Mantellini P. Endoscopy. 2021 Feb 1. doi:...
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy
Montopoli M, Zorzi M, Cocetta V, Prayer-Galetti T, Guzzinati S, Bovo E, Rugge M, Calcinotto A. Ann Oncol. 2021 Jan 29:S0923-7534(21)00097-1. doi: 10.1016/j.annonc.2021.01.069. Online ahead of print. Pubmed https://pubmed.ncbi.nlm.nih.gov/33524477/
Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy
Dal Maso L, Panato C, De Paoli A, Mattioli V, Serraino D, Elisei R, Zoppini G, Gobitti C, Borsatti E, Di Felice E, Falcini F, Ferretti S, Francisci S, Giorgi Rossi P, Guzzinati S, Mazzoleni G, Pierannunzio D, Piffer S, Vaccarella S, Vicentini M, Zorzi M, Franceschi S,...
The Economic Impact of Rectal Cancer: A Population-Based Study in Italy
Gigli A, Francisci S, Capodaglio G, Pierannunzio D, Mallone S, Tavilla A, Lopez T, Zorzi M, Stracci F, Busco S, Mazzucco W, Lonardi S, Bianconi F, Russo AG, Iacovacci S, Serraino D, Manneschi G, Fusco M, Cusimano R, Rugge M, Guzzinati S. Int J Environ Res Public...
Adherence to Mediterranean Diet, Physical Activity and Survival after Prostate Cancer Diagnosis
Di Maso M, Augustin LSA, Toffolutti F, Stocco C, Dal Maso L, Jenkins DJA, Fleshner NE, Serraino D, Polesel J. Nutrients. 2021 Jan 16;13(1):243. doi: 10.3390/nu13010243. AbstractDespite the considerable number of studies investigating the Mediterranean diet in prostate...
Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in Italy
Bucchi L, Mancini S, Crocetti E, Dal Maso L, Baldacchini F, Vattiato R, Giuliani O, Ravaioli A, Caldarella A, Carrozzi G, Ferretti S, Filiberti RA, Fusco M, Gatti L, Gili A, Magoni M, Mangone L, Mazzoleni G, Michiara M, Panato C, Piffer S, Piras D, Rosso S, Rugge M,...
Histological assessment of gastric pseudopyloric metaplasia: Intra- and inter-observer consistency
Rugge M, Sacchi D, Genta RM, Zanco F, Guzzinati S, Pizzi M, Fassan M, Di Sabatino A, El-Serag H. Dig Liver Dis. 2021 Jan;53(1):61-65. doi: 10.1016/j.dld.2020.09.003. Epub 2020 Sep 28. Abstract Background: The histological spectrum of oxyntic mucosal atrophy (a major...
The Economic Impact of Rectal Cancer: A Population-Based Study in Italy List of Authors
Gigli A, Francisci S, Capodaglio G, Pierannunzio D, Mallone S, Tavilla A, Lopez T, Zorzi M, Stracci F, Busco S, Mazzucco W, Lonardi S, Bianconi F, Russo AG, Iacovacci S, Serraino D, Manneschi G, Fusco M, Cusimano R, Rugge M, Guzzinati S. Int J Environ Res Public...
Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study
Gori S, Battagello J, Gustinucci D, Campari C, Zorzi M, Frayle H, Passamonti B, Sartori G, Bulletti S, Fodero C, Cesarini E, Faggiano R, Del Mistro A. BJOG. 2020 Dec 16. doi: 10.1111/1471-0528.16631. Online ahead of print. Abstract Objective: To evaluate partial...
Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates
Mantellini P, Battisti F, Armaroli P, Giubilato P, Ventura L, Zorzi M, Battagello J, Sassoli de Bianchi P, Senore C, Zappa M. Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):344-352. doi: 10.19191/EP20.5-6.S2.136. Abstract Objectives: to describe the course of Italian...
New information flows for cancer registries: testing the use of laboratory data in the province of Reggio Emilia, Italy
Roncaglia F, Mancuso P, Vicentini M, Vitiello A, Vecchia L, Luminari S, Mangone L, Zorzi M, La Vecchia C, Giorgi Rossi P. Eur J Cancer Prev. 2020 Nov;29(6):548-555. doi: 10.1097/CEJ.0000000000000585. Abstract Introduction: Haematological malignancies often escape the...
Adherence to the Mediterranean Diet and Mortality after Breast Cancer
Di Maso M, Maso LD, Augustin LSA, Puppo A, Falcini F, Stocco C, Mattioli V, Serraino D, Polesel J. Nutrients. 2020 Nov 27;12(12):3649. doi: 10.3390/nu12123649. Abstract Adherence to Mediterranean diet has been consistently associated with a reduced mortality in the...
Epidemiology and public health response in early phase of COVID-19 pandemic, Veneto Region, Italy, 21 February to 2 April 2020
Russo F, Pitter G, Da Re F, Tonon M, Avossa F, Bellio S, Fedeli U, Gubian L, Monetti D, Saia M, Zanella F, Zorzi M, Narne E, Mantoan D. Euro Surveill. 2020 Nov;25(47):2000548. doi: 10.2807/1560-7917.ES.2020.25.47.2000548. Abstract BackgroundVeneto was one of the...
Use of an Artificial Neural Network to Identify Patient Clusters in a Large Cohort of Patients with Melanoma by Simultaneous Analysis of Costs and Clinical Characteristics
Damiani G, Buja A, Grossi E, Rivera M, De Polo A, De Luca G, Zorzi M, Vecchiato A, Del Fiore P, Saia M, Baldo V, Rugge M, Rossi CR, Damiani G. Acta Derm Venereol. 2020 Nov 18;100(18):adv00323. doi: 10.2340/00015555-3680. ...
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population
Benevolo M, Mancuso P, Allia E, Gustinucci D, Bulletti S, Cesarini E, Carozzi FM, Confortini M, Bisanzi S, Rubino T, Rollo F, Marchi N, Farruggio A, Pusiol T, Venturelli F, Giorgi Rossi P; New Technologies for Cervical Cancer 2 (NTCC2) Working Group. Cancer...
Cancer prevalence by phase of care: an indicator for assessing health service needs
Gigli A, Francisci S, Guzzinati S, Hall A, Hachey M, Scoppa S, Mariotto A. Tumori. 2020 Oct 23:300891620961839. doi: 10.1177/0300891620961839. Online ahead of print. Abstract Introduction: Cancer prevalence (people alive on a certain date in a population who...
Il Registro Tumori Veneto ha ottenuto la certificazione di qualità ISO 9001:2015
Il Registro Tumori del Veneto ha ottenuto da Bureau Veritas (riconosciuto presso ACCREDIA, l’Ente nazionale per l’accreditamento) la certificazione di qualitàISO 9001:2015. Si tratta di un risultato unico a livello nazionale, che arriva a termine di un percorso durato...
The Veneto Tumour Registry has obtained the ISO 9001:2015 quality certification
The Veneto Tumour Registry has obtained the ISO 9001:2015 quality certification from Bureau Veritas (recognized by ACCREDIA, the Italian Accreditation Body). This is a unique result at national level, which comes at the end of a one-year process: all the activities...
Pubblicate le stime di incidenza al 2020
Sono pubblicate alla pagina https://www.registrotumoriveneto.it/it/pubblicazioni/monografie/per-area le stime dei casi incidenti in Veneto nel 2020 per le principali sedi tumorali. Le stime sono disponibili per il totale della Regione e per le singole ULSS.
Cancer cure for 32 cancer types: results from the EUROCARE-5 study
Dal Maso L, Panato C, Tavilla A, Guzzinati S, Serraino D, Mallone S, Botta L, Boussari O, Capocaccia R, Colonna M, Crocetti E, Dumas A, Dyba T, Franceschi S, Gatta G, Gigli A, Giusti F, Jooste V, Minicozzi P, Neamtiu L, Romain G, Zorzi M, De Angelis R, Francisci S;...
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, Giorgi Rossi P, Marino M, Zorzi M, Bovo E, Leoni O, Ludergnani M, Spila Alegiani S; ITA-COVID-19: RAAS inhibitor group. [published online ahead of print, 2020 Aug 27]. Drug Saf. 2020. doi:...
Impact of Rhabdomyosarcoma Treatment Modalities by Age in a Population-Based Setting
Ferrari A, Bernasconi A, Bergamaschi L, Botta L, Andreano A, Castaing M, Rugge M, Bisogno G, Falcini F, Sacerdote C, Tagliabue G, Michiara M, Cirilli C, Barchielli A, Filiberti RA, Vitale MF, Tumino R, Stracci F, Chiaravalli S, Casanova M, Gasparini P, Milano GM,...
Colonoscopy related adverse events and mortality in an Italian organized colorectal cancer screening program
Benazzato L, Zorzi M, Antonelli G, Guzzinati S, Hassan C, Fantin A. [published online ahead of print, 2020 Jul 28]. Endoscopy. 2020;10.1055/a-1228-9225. doi:10.1055/a-1228-9225 Abstract Background and Aims Post-colonoscopy adverse events (AE) are a key quality...
SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer
Rugge M., Zorzi M. & Guzzinati S. Nat Cancer (2020). https://doi.org/10.1038/s43018-020-0104-9 Abstract In 84,246 consecutive Italians tested for SARS-CoV-2, we examined the prevalence of cancer and clinical outcomes of viral infection. Overall, 5.7%...
Pubblicato su Nature Cancer uno studio su COVID e tumori
La prestigiosa rivista Nature Cancer ha pubblicato uno studio del Registro Tumori del Veneto, in cui è stato valutato se una pregressa diagnosi di tumore influisce negativamente sugli esiti dell’infezione da COVID-19. Dalle analisi, effettuate su 84,246 residenti...
Privacy Policy
INFORMAZIONI SUL TRATTAMENTO DI DATI PERSONALIai sensi e per gli effetti dell’art. 13 e 14 del Regolamento (UE) 2016/679 Premessa Con DGRV n. 2024 del 6 dicembre 2017, il Registro Tumori del Veneto è stato trasferito ad Azienda Zero che pertanto, in qualità di...
Patterns of Care and Cost Profiles of Women With Breast Cancer in Italy: EPICOST Study Based on Real World Data
Francisci S, Guzzinati S, Capodaglio G, Pierannunzio D, Mallone S, Tavilla A, Lopez T, Busco S, Mazzucco W, Angiolini C, Zorzi M, Serraino D, Barchielli A, Fusco M, Stracci F, Bianconi F, Rugge M, Iacovacci S, Russo AG, Cusimano R, Gigli A. Eur J Health Econ. 2020 May...
Interval colorectal cancers after negative faecal immunochemical test in a 13-year screening programme
Zorzi M, Hassan C, Senore C, Capodaglio G, Turrin A, Narne E, Mussato A, Rizzato S, Chinellato E, Zamberlan S, Repici A, Rugge M. J Med Screen. 2020 May 11:969141320918613. doi: 10.1177/0969141320918613. Online ahead of print. Abstract Objective: To assess faecal...
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, Carbone GM, Cavalli A, Pagano F, Ragazzi E, Prayer-Galetti T, Alimonti A. Ann Oncol. 2020 May 4:S0923-7534(20)39797-0. doi: 10.1016/j.annonc.2020.04.479. Online ahead of print. Abstract Background:...
Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer
Zorzi M, Hassan C, Capodaglio G, Baracco M, Antonelli G, Bovo E, Rugge M. Endoscopy. 2020 Apr 30. doi: 10.1055/a-1159-0644. Online ahead of print. Abstract BACKGROUND : Colorectal cancer (CRC) screening programs based on fecal immunochemical testing (FIT) generate...
A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients
Rastrelli M, Del Fiore P, Buja A, Vecchiato A, Rossi CR, Chiarion Sileni V, Tropea S, Russano F, Zorzi M, Spina R, Cappellesso R, Mazzarotto R, Cavallin F, Bassetto F, Bezzon E, Ferrazzi B, Alaibac M, Mocellin S. Front Oncol. 2020 Apr 15;10:529. doi:...
Adolescent and Young Adult Cancer Survivors: Design and Characteristics of the First Nationwide Population-Based Cohort in Italy
Bernasconi A, Barigelletti G, Tittarelli A, Botta L, Gatta G, Tagliabue G, Contiero P, Guzzinati S, Andreano A, Manneschi G, Falcini F, Castaing M, Filiberti RA, Gasparotti C, Cirilli C, Mazzucco W, Mangone L, Iacovacci S, Vitale MF, Stracci F, Piffer S, Tumino R,...
Do We Need a New Paradigm for Assessing the Accuracy of Fecal Immunochemical Test Screening?
Senore C, Zorzi M. Clin Gastroenterol Hepatol. 2020 Apr 11. pii: S1542-3565(20)30489-4. doi: 10.1016/j.cgh.2020.04.008. [Epub ahead of print].
Incidence trends of vulvar squamous cell carcinoma in Italy from 1990 to 2015
Mancini S, Bucchi L, Baldacchini F, Giuliani O, Ravaioli A, Vattiato R, Preti M, Tumino R, Ferretti S, Biggeri A, Brustolin A, Boschetti L, Caiazzo AL, Caldarella A, Cesaraccio R, Cirilli C, Citarella A, Filiberti RA, Fusco M, Galasso R, Gatti L, Lotti FL, Magoni M,...
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
Cuzick J, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Del Mistro A, Frayle H, Girlando S, Sani C, Confortini M, Zorzi M, Giorgi-Rossi P, Rizzolo R, Ronco G; New Technologies for Cervical Cancer Screening Working Group. Int J Cancer. 2020 Mar 14. doi:...
Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer.
Campostrini F, Remo A, Astati L, Zorzi M, Capodaglio G, Buffoli A, Moretti G, Della Monica B, Zanella C, Verlato G. Strahlenther Onkol. 2020 Mar 12. doi: 10.1007/s00066-020-01590-3. [Epub ahead of print]
Real-world Strategies for Colorectal Cancer Screening Based on Studies From The Netherlands
Selby K, Zorzi M. Clin Gastroenterol Hepatol. 2020 Mar;18(3):546-547. doi: 10.1016/j.cgh.2019.09.013. Epub 2019 Sep 13.
Differences in direct costs of patients with stage I cutaneous melanoma: A real-world data analysis
Buja A, Rivera M, De Polo A, Zorzi M, Baracco M, Italiano I, Vecchiato A, Del Fiore P, Guzzinati S, Saia M, Baldo V, Rugge M, Rossi CR. Eur J Surg Oncol. 2020 Feb 19. pii: S0748-7983(20)30119-0. doi: 10.1016/j.ejso.2020.02.017. [Epub ahead of print] Review. Abstract...
Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates
Zorzi M, Zappa M; AIRTUM Working Group. Gut. 2020 Feb;69(2):311-316. doi: 10.1136/gutjnl-2019-318589. Epub 2019 Apr 30. Abstract OBJECTIVE:The impact of a screening programme on colorectal cancer (CRC) incidence in its target population depends on several variables,...
Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study
Bielska-Lasota M, Rossi S, Krzyżak M, Haelens A, Domenic A, De Angelis R, Maciejczyk A, Rodríguez-Barranco M, Zadnik V, Minicozzi P; EUROCARE-5 Working Group. Arch Gynecol Obstet. 2020 Feb;301(2):591-602. doi: 10.1007/s00404-019-05412-5. Epub 2019 Dec 18. Abstract...
Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow-up
Zorzi M, Del Mistro A, Giorgi Rossi P, Laurino L, Battagello J, Lorio M, Soldà M, Martinotti Gabellotti E, Maran M, Dal Cin A, Fiore A, Rugge M, Maggino T. Int J Cancer. 2020 Jun 1;146(11):3114-3123. doi: 10.1002/ijc.32695. Epub 2019 Oct 15. Abstract Aim of this...
Health Outcomes and Direct Healthcare Costs in Patients with Melanoma: Associations with Level of Education
Buja A, Rivera M, Zorzi M, Sperotto M, Baracco S, Italiano I, Vecchiato A, Del Fiore P, Avossa F, Corti MC, Guzzinati S, Saia M, Baldo V, Rugge M, Rossi CR. Acta Derm Venereol. 2020 Jan 7;100(1):adv00003. doi: 10.2340/00015555-3329.
Real-world data for direct stage-specific costs of melanoma healthcare
Buja A, Rivera M, De Polo A, Zorzi M, Carpin E, Vecchiato A, Del Fiore P, Martin G, Saia M, Baldo V, Rugge M, Rossi CR. Br J Dermatol. 2020 Jan 29. doi: 10.1111/bjd.18896. [Epub ahead of print].
Decline in the incidence of colorectal cancer and the associated mortality in young Italian adults
Zorzi M, Cavestro GM, Guzzinati S, Dal Maso L, Rugge M; AIRTUM Working Group. Gut. 2019 Dec 16. pii: gutjnl-2019-320406. doi: 10.1136/gutjnl-2019-320406. [Epub ahead of print]
Cost-effectiveness of a melanoma screening programme using whole disease modelling
Buja A, Rivera M, Girardi G, Vecchiato A, Rebba V, Pizzo E, Sileni VC, Palozzo AC, Montesco M, Zorzi M, Sartor G, Scioni M, Bolzan M, Fiore PD, Bonavina MG, Rugge M, Baldo V, Rossi CR. J Med Screen. 2019 Nov 11:969141319885998. doi: 10.1177/0969141319885998. [Epub...
Stable prevalence of faecal immunochemical test positivity over time in Italy
Zorzi M, Battagello J, Rugge M. J Med Screen. 2019 Nov 4:969141319884593. doi: 10.1177/0969141319884593. [Epub ahead of print]
Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study
Del Mistro A, Giorgi Rossi P, Frayle H, Pasquale L, Campari C, Ronco G, Zorzi M. BJOG. 2019 Oct;126(11):1365-1371. doi: 10.1111/1471-0528.15893. Epub 2019 Aug 25. Abstract OBJECTIVE:To assess the 5-year risk of high-grade lesions in women with a transient high-risk...
Changes in life expectancy for cancer patients over time since diagnosis
Botta L, Dal Maso L, Guzzinati S, Panato C, Gatta G, Trama A, Rugge M, Tagliabue G, Casella C, Caruso B, Michiara M, Ferretti S, Sensi F, Tumino R, Toffolutti F, Russo AG, Caiazzo AL, Mangone L, Mazzucco W, Iacovacci S, Ricci P, Gola G, Candela G, Sutera Sardo A, De...
Prognosis and cure of long-term cancer survivors: A population-based estimation
Dal Maso L, Panato C, Guzzinati S, Serraino D, Francisci S, Botta L, Capocaccia R, Tavilla A, Gigli A, Crocetti E, Rugge M, Tagliabue G, Filiberti RA, Carrozzi G, Michiara M, Ferretti S, Cesaraccio R, Tumino R, Falcini F, Stracci F, Torrisi A, Mazzoleni G, Fusco M,...
Failure to rescue as a source of variation in hospital mortality after rectal surgery: The Italian experience
Spolverato G, Gennaro N, Zorzi M, Rugge M, Mescoli C, Saugo M, Corti MC, Pucciarelli S. Eur J Surg Oncol. 2019 Mar 16. pii: S0748-7983(19)30313-0. doi: 10.1016/j.ejso.2019.03.006 Abstract INTRODUCTIONFailure to rescue (FTR) patients from postoperative complications...
Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging
Rugge M, Sugano K, Scarpignato C, Sacchi D, Oblitas WJ, Naccarato AG. Helicobacter. 2019 Apr;24(2):e12571. doi: 10.1111/hel.12571. Epub 2019 Feb 17. Abstract Gastric cancer (GC) ranks among the most lethal epithelial malignancies, and its striking mortality rate...
Professor Massimo Rugge is the new President of AIRTUM – ASSOCIAZIONE ITALIANA REGISTRI TUMORI (ITALIAN ASSOCIATION OF TUMOUR REGISTRIES)
Professor Massimo Rugge, Scientific Director of the Veneto Tumour Registry and Director of the Unit of Pathology at the University of Padova, was elected President of AIRTUM - Associazione Italiana Registri Tumori (Italian Association of Tumour Registries). The...
Incidence, survival and prevalence of myeloid malignancies in Europe
Visser O, Trama A, Maynadié M, Stiller C, Marcos-Gragera R, De Angelis R, Mallone S, Tereanu C, Allemani C, Ricardi U, Schouten HC; RARECARE Working Group. Eur J Cancer. 2012 Nov;48(17):3257-66. doi: 10.1016/j.ejca.2012.05.024. Epub 2012 Jul 4. Abstract...
Air pollution and childhood leukaemia: a nationwide case-control study in Italy
Badaloni C, Ranucci A, Cesaroni G, Zanini G, Vienneau D, Al-Aidrous F, De Hoogh K, Magnani C, Forastiere F; SETIL Study Group. Occup Environ Med. 2013 Dec;70(12):876-83. doi: 10.1136/oemed-2013-101604. Epub 2013 Sep 18. Abstract OBJECTIVES:Leukaemia is the most...
Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project
Mallone S, De Angelis R, van der Zwan JM, Trama A, Siesling S, Gatta G, Capocaccia R; RARECARE WG. Cancer Epidemiol. 2013 Dec;37(6):850-6. doi: 10.1016/j.canep.2013.08.001. Epub 2013 Sep 16. Abstract This paper describes the usage and the performance evaluation of...
Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study
Leclère B, Molinié F, Trétarre B, Stracci F, Daubisse-Marliac L, Colonna M; GRELL Working Group. Cancer Epidemiol. 2013 Oct;37(5):544-9. doi: 10.1016/j.canep.2013.05.001. Epub 2013 Jun 12. Abstract Young women are not usually screened for breast cancer (BC). The...
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project
Trama A, Mallone S, Ferretti S, Meduri F, Capocaccia R, Gatta G; RITA working group. Tumori. 2012 Sep-Oct;98(5):550-8. doi: 10.1700/1190.13194. Abstract AIMS AND BACKGROUND:The project Surveillance of rare cancers in Italy (RITA) provides, for the first time,...
Le dimensioni del fenomeno “lungoviventi”: quante sono le persone che vivono dopo una diagnosi di tumore?
Guzzinati S, Dal Maso L. In Un nuovo benessere. La qualità della vita dopo la malattia tumorale. Ed. 2013. Biblioteca di testi e studi (886) . ISBN: 9788843070497 ...
XXII Riunione Annuale AIRTUM. Venezia 11-13 aprile 2018
La XXII Riunione scientifica annuale dell’Associazione Italiana Registri Tumori avrà luogo a VENEZIA dall'11 al 13 aprile 2018. Maggiori informazioni nel sito dell'AIRTUM. Programma del ConvegnoDownload
Extraction of cancer information from pathology clinical records using text mining
Belloni P., Boccuzzo G., Guzzinati S., Italiano I., Scarpa B., Rossi C.R., Rugge M., Zorzi M. Data Science & Social Research 2019 - 2nd international conference on data science and social research Milan, 4-5 February 2019 Abstract Valuable information is stored...
Extraction of cancer information from pathology clinical records using text mining
Belloni P., Boccuzzo G., Guzzinati S., Italiano I., Scarpa B., Rossi C.R., Rugge M., Zorzi M. Data Science & Social Research 2019 - 2nd international conference on data science and social research Milano, 4-5 Febbraio 2019 Abstract Valuable information is stored...
Impatto sull’incidenza del tumore del colon retto dei programmi di screening
Zorzi M, Rizzato S, Busato C, Fiore A, Martin G, Memo L, Carpin E, Dal Cin A, Baracco M, Rugge M XXIII Riunione scientifica AIRTUM 2019 Trapani, 27-29 marzo 2019 Abstract INTRODUZIONEL’impatto dei programmi di screening colorettale sui tassi di incidenza del tumore...
I trend nelle regioni italiane
Andreano A, Buzzoni C, Guzzinati S, Russo AG XXIII Riunione scientifica AIRTUM 2019 Trapani, 27-29 marzo 2019 Abstract INTRODUZIONEPer il presente lavoro sono stati utilizzati i dati dei Registri Tumori italiani, disponibili nella banca Dati AIRTUM a gennaio 2018,...
Estimating the number of people in italy living after a childhood cancer using the software Comprev
Francisci S, Guzzinati S, Dal Maso L, Gigli A 41th IACR Conference Vancouver, Canada 9-13 June 2019 Abstract BACKGROUND Childhood cancer survival grew during the last decades. Consequently, there is an increasing number of adults requiring appropriate follow-up care...
Estimating the number of people in italy living after a childhood cancer using the software Comprev
Francisci S, Guzzinati S, Dal Maso L, Gigli A 41th IACR Conference Vancouver, Canada 9-13 June 2019 Abstract BACKGROUND Childhood cancer survival grew during the last decades. Consequently, there is an increasing number of adults requiring appropriate follow-up care...
Veneto tumour Registry: implementing NAP-coding in cancer registration
Guzzinati S, Zorzi M, Baracco M, Baracco S, Bovo E, Busato C, Carpin E, Chinellato E, Dal Cin A, Fiore AR, Greco A, Martin G, Memo L, Monetti D, Rizzato S, Rosano A, Stocco C, Zamberlan S, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin,...
Veneto tumour Registry: implementing NAP-coding in cancer registration
Guzzinati S, Zorzi M, Baracco M, Baracco S, Bovo E, Busato C, Carpin E, Chinellato E, Dal Cin A, Fiore AR, Greco A, Martin G, Memo L, Monetti D, Rizzato S, Rosano A, Stocco C, Zamberlan S, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin,...
Esophageal cancer in the Veneto Region: when pathology-based Cancer Registry does no fit to the expectancies
Sacchi D, Fanelli G N, De Marchi D, Zorzi M, Guzzinati S, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin, 16-18 October 2019 Abstract Introduction In the last decades, consistently all over the industrialized world, a decreased...
Esophageal cancer in the Veneto Region: when pathology-based Cancer Registry does no fit to the expectancies
Sacchi D, Fanelli G N, De Marchi D, Zorzi M, Guzzinati S, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin, 16-18 October 2019 Abstract Introduction In the last decades, consistently all over the industrialized world, a decreased...
Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia
Sacchi D, Guzzardo V, Guzzinati S, Pizzi M, Fassan M, Cesaro S, Pennelli G, Maddalo G, Albertoni L, Zanco F, Farinati F, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin, 16-18 October 2019 Abstract Introduction Autoimmune gastritis...
Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia
Sacchi D, Guzzardo V, Guzzinati S, Pizzi M, Fassan M, Cesaro S, Pennelli G, Maddalo G, Albertoni L, Zanco F, Farinati F, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin, 16-18 October 2019 Abstract Introduction Autoimmune gastritis...
Natural history of autoimmune gastritis: prospective long-term follow-up clinico-pathological study
Sacchi D, Cesaro S, Guzzinati S, Pizzi M, Zorzi M, Fassan M, Guzzardo V Mescoli C, Maddalo G, Salmaso R, Farinati F, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin, 16-18 October 2019 Abstract Introduction Autoimmune Gastritis (AiG) is...
Natural history of autoimmune gastritis: prospective long-term follow-up clinico-pathological study
Sacchi D, Cesaro S, Guzzinati S, Pizzi M, Zorzi M, Fassan M, Guzzardo V Mescoli C, Maddalo G, Salmaso R, Farinati F, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin, 16-18 October 2019 Abstract Introduction Autoimmune Gastritis (AiG) is...
Cost profiles of breast cancer female patients in Italy: results from the Epicost study
Francisci S, Busco S, Capodaglio G, Gigli A, Guzzinati S, Lopez T, Mallone S, Pierannunzio D, Tavilla A, Zorzi M GRELL Ascension Meeting, Lisbon, 29-31 May 2019 Abstract Objectives The number of women with a breast cancer diagnosis is growing and sustainability of...
Cost profiles of breast cancer female patients in Italy: results from the Epicost study
Francisci S, Busco S, Capodaglio G, Gigli A, Guzzinati S, Lopez T, Mallone S, Pierannunzio D, Tavilla A, Zorzi M GRELL Ascension Meeting, Lisbon, 29-31 May 2019 Abstract Objectives The number of women with a breast cancer diagnosis is growing and sustainability of...
Il Registro Tumori Veneto è “regionale”
Dal 31 dicembre del 2018, il Registro Tumori del Veneto (RTV) censisce la patologia neoplastica di tutti i 4.900.000 residenti nel Veneto. Nessuna area della Regione è esclusa da questo censimento e tale “regionalità” è unica, nella nazione, per le Regioni a elevata...
The Veneto Tumour Registry is “regional”
Cancer Epidemiology is a priority of the Veneto Public Health Care system. Since January 1st 2014 to December 2015, all incident cancer-cases occurring in the whole resident population of the Veneto Region (4,900,000 inhabitants) have been included in the official...
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients
Rugge M, Genta RM, Fassan M, Valentini E, Coati I, Guzzinati S, Savarino E, Zorzi M, Farinati F, Malfertheiner P. Am J Gastroenterol. 2018 Nov;113(11):1621-1628. doi: 10.1038/s41395-018-0353-8. Epub 2018 Oct 17. Abstract OBJECTIVESGastritis OLGA-staging ranks the...
Impact of breast cancer screening in a population with high spontaneous coverage with mammography
Capodaglio G., Zorzi M., Tognazzo S., Greco A., Michieletto F., Fedato C., Montaguti A., Turrin A., Ferro A., Cinquetti S., Russo F., Corti M.C., Rugge M., Fedeli U. Tumori Journal, 6 August 2018, doi.org/10.1177/0300891618792439 AbstractOBJECTIVEThe impact of...
Impact of breast cancer screening in a population with high spontaneous coverage with mammography
Capodaglio G., Zorzi M., Tognazzo S., Greco A., Michieletto F., Fedato C., Montaguti A., Turrin A., Ferro A., Cinquetti S., Russo F., Corti M.C., Rugge M., Fedeli U. Tumori Journal, 6 August 2018, doi.org/10.1177/0300891618792439 AbstractOBJECTIVEThe impact of...
The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998-2012
Dal Maso L, Panato C, Franceschi S, Serraino D, Buzzoni C, Busco S, Ferretti S, Torrisi A, Falcini F, Zorzi M, Cirilli C, Mazzucco W, Magoni M, Collarile P, Pannozzo F, Caiazzo AL, Russo AG, Gili A, Caldarella A, Zanetti R, Michiara M, Mangone L, Filiberti RA, Fusco...
Do not leave FIT positives alone!
Zorzi M, Hassan C, Selby K, Rugge M. Am J Gastroenterol. 2018 Jun;113(6):913. doi: 10.1038/s41395-018-0019-6. Epub 2018 Feb 23. No abstract available.
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
Fassan M, Vianello L, Sacchi D, Fanelli GN, Munari G, Scarpa M, Cappellesso R, Loupakis F, Lanza C, Salmaso R, Mescoli C, Valeri N, Agostini M, D'Angelo E, Lonardi S, Pucciarelli S, Veronese N, Luchini C, Rugge M. Cancer Cell Int. 2018 Sep 6;18:131. doi:...
Colorectal cancer screening: The surgery rates they are a-changing. A nationwide study on surgical resections in Italy
Zorzi M, Gennaro N, Capodaglio G, Urso EDL, Pucciarelli S, Memo L, Carpin E, Corti M, Rugge M, Fedeli U. Dig Liver Dis. 2019 Feb;51(2):304-309. doi: 10.1016/j.dld.2018.10.011. Epub 2018 Oct 26. Abstract BACKGROUNDGrowing evidence suggests that colorectal cancer...
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference
Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A; RARECAREnet Working Group. Eur J Surg Oncol. 2019 Jan;45(1):60-66. doi: 10.1016/j.ejso.2018.02.006. Epub 2018 Feb 14. Abstract BACKGROUNDGerm-cell tumours (GCT) of the testis and penile squamous cell...
Treatment challenges in and outside a network setting: Head and neck cancers
Orlandi E, Alfieri S, Simon C, Trama A, Licitra L; RARECAREnet Working Group. Eur J Surg Oncol. 2019 Jan;45(1):40-45. doi: 10.1016/j.ejso.2018.02.007. Epub 2018 Feb 14. AbstractHead and neck cancer (HNC) is a rare disease that can affect different sites and is...
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
Imbimbo M, Maury JM, Garassino M, Girard N; RARECAREnet Working Group. Eur J Surg Oncol. 2019 Jan;45(1):75-80. doi: 10.1016/j.ejso.2018.01.078. Epub 2018 Feb 2. AbstractThe management of patients with mesothelioma and thymic malignancy requires continuous...
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group. Eur J Surg Oncol. 2019...
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
Lykoudis PM, Partelli S, Muffatti F, Caplin M, Falconi M, Fusai GK; RARECARENet Working Group. Eur J Surg Oncol. 2019 Jan;45(1):46-51. doi: 10.1016/j.ejso.2017.08.019. Epub 2017 Oct 16. Abstract Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours...
Epidemiology of rare cancers and inequalities in oncologic outcomes
Gatta G, Trama A, Capocaccia R; RARECARENet Working Group. Eur J Surg Oncol. 2019 Jan;45(1):3-11. doi: 10.1016/j.ejso.2017.08.018. Epub 2017 Sep 19. Abstract Rare cancers epidemiology is better known compared to the other rare diseases. Thanks to the long history of...
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study
Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A; RARECAREnet working group. Lancet...
Treatment challenges in and outside a network setting: Soft tissue sarcomas
Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARENet Working Group. Eur J Surg Oncol. 2019 Jan;45(1):31-39. doi: 10.1016/j.ejso.2017.09.015. Epub 2017 Sep 19. Abstract Patients with soft tissue sarcoma (STS) experienced better outcomes when...
Relationship between hospital volume and short-term outcomes: a nationwide population-based study including 75,280 rectal cancer surgical procedures
Pucciarelli S, Zorzi M, Gennaro N, Marchegiani F, Barina A, Rugge M, Zuin M, Perin A, Maretto I, Bergamo F, Boso C, Urso EDL, Frambach P, Corti MC. Oncotarget. 2018 Mar 30;9(24):17149-17159. doi: 10.18632/oncotarget.24699. eCollection 2018 Mar 30. Abstract There is...
Cancer incidence and mortality trends from 2003 to 2014 in Italy
Buzzoni C, Crocetti E, Guzzinati S, Dal Maso L, Francisci S; AIRTUM Working Group. Tumori. 2019 Apr;105(2):121-137. doi: 10.1177/0300891619839844. Epub 2019 Mar 28. Abstract OBJECTIVETo evaluate short-term (2003-2014) cancer incidence and mortality trends in Italy....
Trends of colorectal cancer incidence and mortality rates from 2003 to 2014 in Italy
Zorzi M, Dal Maso L, Francisci S, Buzzoni C, Rugge M, Guzzinati S; AIRTUM Working Group. Tumori. 2019 Mar 27:300891619838336. doi: 10.1177/0300891619838336 Abstract OBJECTIVETo evaluate the trends of colorectal cancer (CRC) incidence and mortality rates from 2003 to...
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients
Rugge M, Meggio A, Pravadelli C, Barbareschi M, Fassan M, Gentilini M, Zorzi M, Pretis G, Graham DY, Genta RM. Gut. 2019 Jan;68(1):11-17. doi: 10.1136/gutjnl-2017-314600. Epub 2018 Jan 6. Abstract OBJECTIVEOperative link on gastritis assessment (OLGA) staging for...
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer. Results from the IMPATTO study
Vicentini M, Zorzi M, Bovo E, Mancuso P, Zappa M, Manneschi G, Mangone L, Rossi PG; Colorectal Cancer Screening IMPATTO study working group. Int J Cancer. 2019 Jan 1;145(1):110-121. doi: 10.1002/ijc.32089. Abstract To evaluate the impact of faecal immunochemical...
Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions
Saraggi D, Salmaso R, Zamuner C, Munari G, Lanza C, Alaibac MS, Bassetto F, Rugge M, Montesco MC, Cerroni L, Fassan M. J Am Acad Dermatol. 2018 Oct;79(4):728-735. doi: 10.1016/j.jaad.2018.06.018. Epub 2018 Jun 18. Abstract BACKGROUNDALK receptor tyrosine kinase gene...
High resolution registry of melanoma and care pathways monitoring in the Veneto Region, Italy
Guzzinati S., Zorzi M., Rossi CR., Buja A., Italiano I., Fiore AR., Dal Cin A., Baracco M., Martin G., Rugge M. ENCR scientific meeting Copenaghen, 26-28 settembre 2018 Abstract AIMIn 2016 the Veneto Region issued the care pathways for patients with melanoma. The...
The American journal “Annals of Internal Medicine” published an analysis of the Veneto Tumour Registry
The American journal “Annals of Internal Medicine” published an analysis of the Veneto Tumour Registry on the performance of colorectal cancer screening programs for detecting lesions located in the proximal colon, in the distal colon and in the rectum. The study...
The Veneto Cancer Registry involved in a multicentre European study: EU-MELACARE
The Veneto Cancer Registry is involved in a multicentre European study (EU-MELACARE) whose main objective is to reduce the disparities and increase the overall quality of care of patients with melanoma among European regions. This paper reports on information recorded...
Il Professor Massimo Rugge è stato eletto Presidente dell’Associazione Italiana Registri Tumori (AIRTum)
Il Professor M. Rugge, Direttore dell’Istituto di Anatomia Patologica dell’Università degli Studi di Padova e Direttore scientifico del Registro Tumori del Veneto, è stato eletto Presidente dell’Associazione Italiana Registri Tumori (AIRTum). L’elezione è avvenuta a...
The breast cancer screening programmes reduce the cause-specific mortality: new research published in Tumori Journal
We published in the peer-reviewed international scientific journal “Tumori Journal” the results of a research that showed that breast cancer screening programmes in the Veneto region reduced the cause-specific mortality by 16%, as compared with the spontaneous...
Il Registro Tumori del Veneto coinvolto nel nuovo progetto Europeo: Eu-Melacare
Il Registro Tumori del Veneto ha preso parte ad uno studio collaborativo Europeo (EU-MELACARE), il cui obiettivo principale è creare le condizioni per un miglioramento della qualità della gestione dei pazienti affetti da melanoma nei Paesi dell’Europa. Lo studio...
La rivista americana “Annals of Internal Medicine” pubblica uno studio del Registro Tumori del Veneto
La prestigiosa rivista americana “Annals of Internal Medicine” ha pubblicato uno studio condotto dal Registro Tumori del Veneto sull’efficacia dei programmi di screening colorettale nel contrastare il tumore del colon retto a livello del colon prossimale, del colon...
L’esperienza di EPICOST: indicatori di percorso per interpretare i profili di costo dei pazienti oncologici
Francisci S., Busco S., Capodaglio G., Gigli A., Guzzinati S., Lopez T., Mallone S., Pierannunzio D., Tavilla D. e EPICOST working group. XXII Riunione scientifica annuale AIRTUM Venezia, 11-13 aprile 2018 Abstract OBIETTIVIIn Italia cresce il numero di pazienti...
Confronto tra metodologia MCMC e INLA in modelli gerarchici bayesiani nella valutazione spaziale del rischio d’incidenza
Bovo E., Girardi P., Stocco C., Baracco S., Rosano A., Monetti D., Rizzato S., Zamberlan S., Chinellato E., Rugge M. XXII Riunione scientifica annuale AIRTUM Venezia, 11-13 aprile 2018 Abstract OBIETTIVIRecentemente l’utilizzo di metodi approssimati quali INLA...
Percorsi di cura e profili di costo di pazienti oncologici: lo studio Epicost
Gigli A., Francisci S., Guzzinati S., Capodaglio G., Pierannunzio D., Mallone S., Tavilla A., Lopez T., Busco S., AIRTUM WG XLII Congresso AIE Lecce, 24-26 ottobre 2018 Abstract INTRODUZIONEIn Italia continua a crescere il numero di pazienti oncologici e il loro...
Registrazione ad alta risoluzione dei melanomi e monitoraggio del PDTA della Regione Veneto
Zorzi M., Rossi CR., Buja A., Italiano I., Fiore AR., Dal Cin A., Baracco M., Martin G., Guzzinati S., Rugge M. XXII Riunione scientifica annuale AIRTUM Venezia, 11-13 aprile 2018 Abstract OBIETTIVINel 2016 la Regione Veneto ha emanato il PDTA per i pazienti con...
Estensione territoriale del Registro Tumori Veneto e fruibilità dei dati: dalla banca dati AIRTUM al nuovo portale web
Bovo E., Bianconi F., Mogini D., Busato C., Rizzato S., Monetti D., Rosano A., Baracco S., Guzzinati S., Rugge M. XXII Riunione scientifica annuale AIRTUM Venezia, 11-13 aprile 2018 Abstract OBIETTIVIPer rendere facilmente fruibili i dati epidemiologici sui tumori a...
Registrazione delle metastasi scheletriche tramite SDO e schede di morte: uno studio di fattibilità
Zorzi M., Tognazzo S., Bovo E., Zagonel V., Brunello A., Chinellato E., Stocco C., Baracco S., Busato C., Rugge M. XXII Riunione scientifica annuale AIRTUM Venezia, 11-13 aprile 2018 AbstractOBIETTIVIValutare se Schede di dimissione ospedaliera (SDO) e Schede di...
Interazione tra round di screening e sensibilità per tumore del colon retto nello screening colorettale
Zorzi M., Capodaglio G., Mussato A., Turrin A., Fiore A., Carpin E., Memo L., Dal Cin A., Greco A., Rugge M. XXII Riunione scientifica annuale AIRTUM Venezia, 11-13 aprile 2018 AbstractOBIETTIVIValutare l’interazione tra round di screening e sensibilità del test...
Localizzazione anatomica e stadio dei tumori colorettali diagnosticati in soggetti a round di screening ripetuti
Zorzi M., Capodaglio G., Turrin A., Greco A., Carpin E., Zamberlan S., Martin G., Baracco M., Memo L., Rugge M. XXII Riunione scientifica annuale AIRTUM Venezia, 11-13 aprile 2018 AbstractOBIETTIVIValutare l’interazione tra round di screening con sangue occulto...
Video tutorial
Cancro. In Veneto record per sopravvivenza e screening
Il 60,7% degli uomini e il 66,3% delle donne sono vivi a 5 anni da una diagnosi di tumore, contro una media nazionale del 54% degli uomini e del 63% delle donne. Inoltre, nel 2016 il 79% dei cittadini ha fatto il test di prevenzione per il tumore del colon retto, ed...
7/11/2017: Il Registro Tumori del Veneto amplia la copertura della registrazione al 96% della popolazione residente
Il Registro Tumori del Veneto amplia la copertura della registrazione al 96% della popolazione residente. Conferenza stampa Registro Tumori del Veneto.pdfDownload
Politica sui cookies
Utilizzo generale Sul nostro sito utilizziamo i cookie, i tracking pixel e le tecnologie correlate. I cookie sono piccoli file di dati che vengono serviti dalla nostra piattaforma e memorizzati sul dispositivo. Il nostro sito utilizza i cookie lasciati da noi o da...
Veneto Mesothelioma Registry
Veneto Mesothelioma Registry INTRO The aim of the Mesothelioma Registry is to identify all the cases of mesothelioma occurring in the Veneto Region, and to investigate the patients’ professional, domestic and environmental history. METHODS The procedures for...
Cookies Policy
General Use We use cookies, tracking pixels and related technologies on our website. Cookies are small data files that are served by our platform and stored on your device. Our site uses cookies dropped by us or third parties for a variety of purposes including to...
Consultazione dati Registro Tumori Veneto
{module Home_datiVeneto} {module Home_datiSedi} {module Home_datiAsl}
Registro Tumori Veneto data
{module Home_datiVenetoEN} {module Home_datiSediEN} {module Home_datiAslEN}
12/02/2018: Accreditation of the extension of the Veneto Tumour Registry to 96% of the regional population is granted by AIRTUM
7/11/2017: The Veneto Tumour Registry increases the coverage of the registration to 96% of the whole regional population
The Veneto Tumour Registry increases the coverage of the registration to 96% of the whole regional population.
XXII AIRTUM annual conference. Venice, 11-13 april 2018
More information on AIRTUM.
16/10/2017: Online the 2008-2010 incidence data of the RTV contained in vol. XI of Cancer Incidence in Five Continents (CI5), published by the International Agency for Research on Cancer (IARC) and the International Association of Cancer Registries (IACR)
See data at http://ci5.iarc.fr/CI5-XI/Default.aspx IARC vol XI.pdfDownload
The Scientific Director introduces the Veneto Tumour Registry
I would like to give a warm welcome to visitors to the Veneto Tumour Registry, and provide a few general details about how this institution forming part of the region’s public health system is organized. This text is intended mainly for non-technical readers. People...
Veneto Tumour Registry during the years
The RTV was formally established by Regional Law n. 11 of 16 February 2010. The norms governing how it functions are contained in Regional Regulations published in 2013 (“Norme per il funzionamento del Registro Tumori del Veneto”), as approved by the Italian Data...
Introduction
The Scientific Director introduces the Veneto Tumour Registry (Registro Tumori del Veneto)I would like to give a warm welcome to visitors to the Veneto Tumour Registry, and provide a few general details about how this institution forming part of the region’s public...
Il Direttore Scientifico presenta il Registro Tumori del Veneto
Desidero dare il benvenuto ai visitatori del Registro Tumori del Veneto e offrire qualche informazione generale sul profilo organizzativo di questa Istituzione della Sanità Regionale. Il testo è elettivamente dedicato agli utilizzatori non-tecnici; i tecnici che hanno...
Nuovo sito Web del Registro Tumori Veneto
È on line il nuovo sito web istituzionale del Registro Tumori del Veneto (RTV): esso renderà disponibile a tutti gli interessati (cittadinanza, decisori sanitari, mondo scientifico) il patrimonio informativo del Registro. Il sito web pubblica i dati epidemiologici dei...
12/02/2018: E’ stata accreditata l’estensione del Registro al 96% della Regione
Lettera di Accreditamento del Presidente AIRTUM.pdfDownload
16/10/2017: Online i dati di incidenza 2008-2010 del RTV contenuti nel vol. XI del Cancer Incidence in Five Continents (CI5), pubblicato dalla Agenzia Internazionale per la Ricerca sul Cancro (IARC) e dall’Associazione Internazionale dei Registri Tumori
Dati disponibili al indirizzo http://ci5.iarc.fr/CI5-XI/Default.aspx Vedi la scheda della Regione Veneto allegata. IARC vol XI.pdfDownload
Statement of Mesoteliomi Registry
The Legislative Decree of the President of the Council of Ministers n. 308/2002 assigned the epidemiological surveillance of mesothelioma cases to the National Registry of Mesotheliomas (ReNaM), established at the Department of Medicine, Epidemiology, and...
Embryonal cancers in Europe
Gatta G, Ferrari A, Stiller CA, Pastore G, Bisogno G, Trama A, Capocaccia R; RARECARE Working Group. Eur J Cancer. 2012 Jul;48(10):1425-33. doi: 10.1016/j.ejca.2011.12.027. Epub 2012 Feb 20. Abstract Embryonal cancers are a heterogeneous group of rare cancers which...
Epidemiology of glial and non-glial brain tumours in Europe
Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, Weber DC, Ricardi U, Slowinski J, Brandes A; RARECARE working group. Eur J Cancer. 2012 Jul;48(10):1532-42. doi: 10.1016/j.ejca.2011.12.013. Epub 2012 Jan 7. Abstract To the central nervous system...
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002
Faivre J, Trama A, De Angelis R, Elferink M, Siesling S, Audisio R, Bosset JF, Cervantes A, Lepage C; RARECARE Working Group. Eur J Cancer. 2012 Jul;48(10):1417-24. doi: 10.1016/j.ejca.2011.10.038. Epub 2011 Dec 9. Abstract BACKGROUND AND AIMS:Little is known about...
Rare thoracic cancers, including peritoneum mesothelioma
Siesling S, Van der Zwan JM, Izarzugaza I, Jaal J, Treasure T, Foschi R, Ricardi U, Groen H, Tavilla A, Ardanaz E; RARECARE Working Group. Eur J Cancer. 2012 May;48(7):949-60. doi: 10.1016/j.ejca.2012.02.047. Epub 2012 Mar 9. Abstract Rare thoracic cancers include...
Incidence and survival of rare urogenital cancers in Europe
Visser O, Adolfsson J, Rossi S, Verne J, Gatta G, Maffezzini M, Franks KN; RARECARE working group. Eur J Cancer. 2012 Mar;48(4):456-64. doi: 10.1016/j.ejca.2011.10.031. Epub 2011 Nov 24. Abstract BACKGROUND:The RARECARE project aims at increasing knowledge of rare...
Rare cancers are not so rare: the rare cancer burden in Europe
Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, Otter R, Licitra L, Mallone S, Tavilla A, Trama A, Capocaccia R; RARECARE working group. Eur J Cancer. 2011 Nov;47(17):2493-511. doi: 10.1016/j.ejca.2011.08.008. Epub 2011 Oct 25. Abstract...
The burden of rare cancers in Europe
Gatta G, Capocaccia R, Trama A, Martínez-García C; RARECARE Working Group. Adv Exp Med Biol. 2010;686:285-303. doi: 10.1007/978-90-481-9485-8_17. Abstract The burden of rare tumors in Europe is still unknown and no generally accepted definition of them exist. The...
Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study
Sant M, Chirlaque Lopez MD, Agresti R, Snchez Prez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larraaga N, Rossi S, Siesling S, Minicozzi P, EUROCARE-5 Working Group. Eur J Cancer. 2015 Oct;51(15):2191-2205. doi:...
Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: results from the EUROCARE-5 study
Trama A, Foschi R, Larraaga N, Sant M, Fuentes-Raspall R, Serraino D, Tavilla A, Van Eycken L, Nicolai N; EUROCARE-5 WG. Eur J Cancer. 2015 Oct;51(15):2206-2216. doi: 10.1016/j.ejca.2015.07.027. Epub 2015 Sep 26. Abstract BACKGROUNDWe provide updated estimates of...
Survival of adults with primary malignant brain tumours in Europe: results of the EUROCARE-5 study
Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P; EUROCARE-5 WG. Eur J Cancer. 2015 Oct;51(15):2231-2241. doi: 10.1016/j.ejca.2015.07.032. Epub 2015 Sep 26. Abstract BACKGROUNDPrimary malignant brain tumours are rare but represent a serious health burden...
Survival patterns in lung and pleural cancer in Europe 1999-2007: results from the EUROCARE-5 study
Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, Knijn A, Pastorino U, Salmern D, Trama A, Sant M; EUROCARE-5 WG. Eur J Cancer. 2015 Oct;51(15):2242-2253. doi: 10.1016/j.ejca.2015.07.033. Epub 2015 Sep 26. Abstract BACKGROUNDSurvival of...
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: results of EUROCARE-5 population-based study
De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadi M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A; EUROCARE-5 WG. Eur J Cancer. 2015 Oct;51(15):2254-2268. doi: 10.1016/j.ejca.2015.08.003. Epub...
Screening for colorectal cancer in Italy: 2011-2012 survey
Zorzi M, Mangone L, Sassatelli R, Baracco S, Budroni M, Castaing M, Cirilli C, Cusimano R, Fusco M, Giacomin A, Giorgi Rossi P, Naldoni C, Pannozzo F, Piffer S, Puppo A, Tisano F, Zappa M; IMPATTO COLONRETTO Working Group. Epidemiol Prev. 2015 May-Jun;39(3 Suppl...
Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial
Bergeron C, Giorgi-Rossi P, Cas F, Schiboni ML, Ghiringhello B, Dalla Palma P, Minucci D, Rosso S, Zorzi M, Naldoni C, Segnan N, Confortini M, Ronco G. J Natl Cancer Inst. 2015 Jan 7;107(2). pii: dju423. doi: 10.1093/jnci/dju423. Print 2015 Feb. Abstract...
Invitation strategies for colorectal cancer screening programmes: the impact of an advance notification letter
Senore C, Ederle A, DePretis G, Magnani C, Canuti D, Deandrea S, Zorzi M, Barca A, Bestagini P, Faitini K, Bisanti L, Casale C, Ferro A, GiorgiRossi P, Quadrino F, Fiorina G, Capuano A, Segnan N, Fantin A. Prev Med. 2015 Apr;73:106-11. doi:...
Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter
Giorgi Rossi P, Fortunato C, Barbarino P, Boveri S, Caroli S, Del Mistro A, Ferro A, Giammaria C, Manfredi M, Moretto T, Pasquini A, Sideri M, Tufi MC, Cogo C, Altobelli E. HPV Self-sampling Italian Working Group. Br J Cancer. 2015 Feb 17;112(4):667-75. doi:...
Changes in cervical cancer incidence following the introduction of organized screening in Italy
Serraino D, Gini A, Taborelli M, Ronco G, Giorgi-Rossi P, Zappa M, Crocetti E, Franzo A, Falcini F, Visioli CB, Stracci F, Zorzi M, Federico M, Michiara M, Fusco M, Ferretti S, Pannozzo F, Tisano F, Zanetti R, Zucchetto A; IMPATTO-CERVICE Working Group. Prev Med. 2015...
Impact of fecal immunochemical test-based screening programs on proximal and distal colorectal cancer surgery rates: a natural multiple-baseline experiment
Fedeli U, Zorzi M, , Urso ED, Gennaro N, Dei Tos AP, Saugo M. Cancer. 2015 Nov 15;121(22):3982-9. doi: 10.1002/cncr.29623. Epub 2015 Aug 11. Abstract BACKGROUNDColorectal cancer (CRC) screening programs based on the fecal immunochemical test (FIT) were found to...
HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs
Campari C, Fedato C, Petrelli A, Zorzi M, Cogo C, Caprioglio A, Gallo F, Giordano L, Domenighini S, Pasquale L, Prandi S, Zappa M, Giorgi Rossi P; GISCi Migrant Working Group. Infect Agent Cancer. 2015 May 7;10:14. doi: 10.1186/s13027-015-0009-x. eCollection 2015. ...
Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: a Retrospective Monoinstitutional Cohort Study
Del Mistro A, Matteucci M, Insacco EA, Onnis G, Da Re F, Baboci L, Zorzi M, Minucci D. Biomed Res Int. 2015;2015:984528. doi: 10.1155/2015/984528. Abstract BACKGROUND The aim of this retrospective observational study of women treated for cervical intraepithelial...
Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results
Campari C, Fedato C, Iossa A, Petrelli A, Zorzi M, Anghinoni E, Bietta C, Brachini A, Brezzi S, Cogo C, Giordano L, Giorgi D, Palazzi M, Petrella M, Schivardi MR, Visioli CB, Giorgi Rossi P; GISCi Migrant Working Group. Eur J Cancer Prev. 2015 Jul 22. Abstract...
La diffusione dei programmi di screening in Italia, anni 2011-2012
Zappa M, Carozzi FM, Giordano L, Sassatelli R, Federici A, Zorzi M, Federici A. Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):5-8. Abstract In this report, we present the results of cancer screening programmes in Italy for the years 2011-2012. This report is produced...
Characteristics of the colorectal cancers diagnosed in the early 2000s in Italy. Figures from the IMPACT study on colorectal cancer screening
Zorzi M, Mangone L, Anghinoni E, Baracco S, Borciani E, Caldarella A, Falcini F, Fanetti AC, Ferretti S, Giorgi Rossi P, Michiara M, Randi G, Stracci F, Vicentini M, Zucchetto A, Zappa M and IMPATTO COLONRETTO working group. Epidemiol Prev 2015; 39(3) Suppl 1:108-14 ...
III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues
Magnani C, Bianchi C, Chellini E, Consonni D, Fubini B, Gennaro V, Marinaccio A, Menegozzo M, Mirabelli D, Merler E, Merletti F, Musti M, Oddone E, Romanelli A, Terracini B, Zona A, Zocchetti C, Alessi M, Baldassarre A, Dianzani I, Maule M, Mensi C, Silvestri S. Med...
Malignant mesothelioma due to non-occupational asbestos exposure from the Italian national surveillance system (ReNaM): epidemiology and public health issues
Marinaccio A, Binazzi A, Bonafede M, Corfiati M, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Merler E, Negro C, Romanelli A, Chellini E, Silvestri S, Cocchioni M, Pascucci C, Stracci F, Ascoli V, Trafficante L, Angelillo I,...
Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry
Corfiati M, Scarselli A, Binazzi A, Di Marzio D, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Merler E, Negro C, Romanelli A, Chellini E, Silvestri S, Cocchioni M, Pascucci C, Stracci F, Romeo E, Trafficante L, Angelillo I, Menegozzo S, Musti M, Cavone...
Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region
Girardi P, Bressan V, Merler E. Cancer Epidemiol 2014;38(5):496-503. Abstract BACKGROUNDMalignant Mesothelioma (MM) is so associated with (professional, familial or environmental) asbestos exposure that trends in incidence and mortality parallel, after 30-40 years,...
Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis
Reid A, de Klerk NH, Magnani C, Ferrante D, Berry G, Musk AW, Merler E. Thorax 2014;69(9):843-50. Abstract BACKGROUNDThe risk of malignant mesothelioma (MM) increases proportionally to the cumulative exposure, and to the 3rd or 4th power of time since first...
Pleural mesothelioma: epidemiological and public health issues. Report from the Second Italian Consensus Conference on Pleural Mesothelioma
Magnani C, Fubini B, Mirabelli D, Bertazzi PA, Bianchi C, Chellini E, Gennaro V, Marinaccio A, Menegozzo M, Merler E, Merletti F, Musti M, Pira E, Romanelli A, Terracini B, Zona A. Med Lav. 2013;104(3):191-202. Abstract Malignant mesothelioma is closely connected to...
Epidemiologic surveillance of mesothelioma for the prevention of asbestos exposure also in non-traditional settings
Binazzi A, Scarselli A, Corfiati M, Di Marzio D, Branchi C, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallenberg G, Merler E, De Zotti R, Romanelli A, Chellini E, Pascucci C, D'Alò D, Forastiere F, Trafficante L, Menegozzo S, Musti M, Cauzillo G, Leotta A, Tumino...
Mesothelioma incidence surveillance systems and claims for workers’ compensation. Epidemiological evidence and prospects for an integrated framework
Marinaccio A, Scarselli A, Merler E, Iavicoli S. BMC Public Health. 2012;12:314. Abstract BACKGROUNDMalignant mesothelioma is an aggressive and lethal tumour strongly associated with exposure to asbestos (mainly occupational). In Italy a large proportion of workers...
Asbestos fibre burden in the lungs of patients with mesothelioma who lived near asbestos-cement factories
Barbieri PG, Mirabelli D, Somigliana A, Cavone D, Merler E. Ann Occup Hyg. 2012;56(6):660-70. Abstract BACKGROUNDEpidemics of malignant mesothelioma are occurring among inhabitants of Casale Monferrato and Bari never employed in the local asbestos-cement (AC)...
Incidence trends of colorectal cancer in the early 2000s in Italy. Figures from the IMPACT study on colorectal cancer screening
Zorzi M, Mangone L, Sassatelli R, Baracco S, Budroni M, Castaing M, Cirilli C, Cusimano R, Fusco M, Giacomin A, Giorgi Rossi P, Naldoni C, Pannozzo F, Piffer S, Puppo A, Tisano F, Zappa M and IMPATTO COLONRETTO working group Epidemiol Prev 2015; 39(3) Suppl 1:115-25....
Economic evaluation of cancer registration in Europe
Zanetti R, Sacchetto L, Calvia M, Bordoni A, Hakulinen T, Znaor A, Møller H, Siesling S, Comber H, Katalinic A, Rosso S; Eurocourse WP3 Working Group. J Registry Manag. 2014 Spring;41(1):31-7. Abstract BACKGROUND:Little has been reported on costs of cancer...
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
Trama A, Mallone S, Nicolai N, Necchi A, Schaapveld M, Gietema J, Znaor A, Ardanaz E, Berrino F; RARECARE Working Group. Eur J Cancer. 2012 Jan;48(2):159-69. doi: 10.1016/j.ejca.2011.08.020. Epub 2011 Dec 3. Erratum inEur J Cancer. 2013 Feb;49(3):766. Abstract We...
Epidemiological surveillance of malignant mesothelioma cases in Italy: incidence and asbestos exposure figures by the Italian mesothelioma registry (ReNaM)
Marinaccio A, Binazzi A, Cauzillo G, Chellini E, De Zotti R, Gennaro V, Menegozzo M, Mensi C, Merler E, Mirabelli D, Musti M, Pannelli F, Romanelli A, Scarselli A, Tosi S, Tumino R, Nesti M; Gruppo di lavoro ReNaM. Epidemiol Prev. Jul-Aug 2007;31(4 Suppl 1):23-6. ...
Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register.
Marinaccio A, Binazzi A, Cauzillo G, Cavone D, Zotti RD, Ferrante P, Gennaro V, Gorini G, Menegozzo M, Mensi C, Merler E, Mirabelli D, Montanaro F, Musti M, Pannelli F, Romanelli A, Scarselli A, Tumino R; Italian Mesothelioma Register (ReNaM) Working Group. Eur J...
Incidence of extrapleural malignant mesothelioma and asbestos exposure, from the Italian national register.
Marinaccio A, Binazzi A, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Merler E, De Zotti R, Mangone L, Chellini E, Pascucci C, Ascoli V, Menegozzo S, Cavone D, Cauzillo G, Nicita C, Melis M, Iavicoli S. Occup Environ Med. 2010...
Non-occupational exposure to asbestos and malignant mesothelioma in the Italian National Registry of Mesotheliomas
Mirabelli D, Cavone D, Merler E, Gennaro V, Romanelli A, Mensi C, Chellini E, Nicita C, Marinaccio A, Magnani C, Musti M. Occup Environ Med. 2010 Nov;67(11):760-5. doi: 10.1136/oem.2009.051466. Epub 2010 Aug 25. Abstract Objectives: The epidemiology of extrapleural...
Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register
Marinaccio A, Binazzi A, Marzio DD, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Riboldi L, Merler E, Zotti RD, Romanelli A, Chellini E, Silvestri S, Pascucci C, Romeo E, Menegozzo S, Musti M, Cavone D, Cauzillo G, Tumino R, Nicita C, Melis M, Iavicoli S;...
Factors Affecting Asbestosis Mortality Among Asbestos-Cement Workers in Italy.
Girardi P, Merler E, Ferrante D, Silvestri S, Chellini E, Angelini A, Luberto F, Fedeli U, Oddone E, Vicentini M, Barone-Adesi F, Cena T, Mirabelli D, Mangone L, Roncaglia F, Sala O, Menegozzo S, Pirastu R, Azzolina D, Tunesi S, Miligi L, Perticaroli P, Pettinari A,...
The epidemiological surveillance of malignant mesothelioma in Italy (1993-2015): methods, findings, and research perspectives
Marinaccio A, Corfiati M, Binazzi A, Di Marzio D, Bonafede M, Verardo M, Migliore E, Gennaro V, Mensi C, Schallemberg G, Mazzoleni G, Fedeli U, Negro C, Romanelli A, Chellini E, Grappasonni I, Pascucci C, Madeo G, Romeo E, Trafficante L, Carrozza F, Angelillo IF,...
Association between asbestos exposure and pericardial and tunica vaginalis testis malignant mesothelioma: a case-control study and epidemiological remarks
Marinaccio A, Consonni D, Mensi C, Mirabelli D, Migliore E, Magnani C, Di Marzio D, Gennaro V, Mazzoleni G, Girardi P, Negro C, Romanelli A, Chellini E, Grappasonni I, Madeo G, Romeo E, Ascoli V, Carrozza F, Angelillo IF, Cavone D, Tumino R, Melis M, Curti S, Brandi...
Asbestos Exposure and Malignant Mesothelioma in Construction Workers-Epidemiological Remarks by the Italian National Mesothelioma Registry (ReNaM)
Binazzi A, Di Marzio D, Verardo M, Migliore E, Benfatto L, Malacarne D, Mensi C, Consonni D, Eccher S, Mazzoleni G, Comiati V, Negro C, Romanelli A, Chellini E, Angelini A, Grappasonni I, Madeo G, Romeo E, Di Giammarco A, Carrozza F, Angelillo IF, Cavone D, Vimercati...
The impact of COVID-19 on new mesothelioma diagnoses in Italy
Mangone L, Mancuso P, Bisceglia I, Giorgi Rossi P, Chellini E, Negro C, Benfatto L, Migliore E, Casotto V, Mensi C, Romanelli A, Tumino R, Grappasonni I, Cavone D, Mazzoleni G, Tallarigo F, Marinaccio A; ReNaM Working Group. Thorac Cancer. 2022 Mar;13(5):702-707. doi:...
Italian pool of asbestos workers cohorts: mortality trends of asbestos-related neoplasms after long time since first exposure
Ferrante D, Chellini E, Merler E, Pavone V, Silvestri S, Miligi L, Gorini G, Bressan V, Girardi P, Ancona L, Romeo E, Luberto F, Sala O, Scarnato C, Menegozzo S, Oddone E, Tunesi S, Perticaroli P, Pettinari A, Cuccaro F, Mattioli S, Baldassarre A, Barone-Adesi F, Cena...
Interval breast cancers in the ‘screening with tomosynthesis or standard mammography’ (STORM) population-based trial
Houssami N, Bernardi D, Caumo F, Brunelli S, Fantò C, Valentini M, Romanucci G, Gentilini MA, Zorzi M, Macaskill P. Breast. 2018 Jan 9;38:150-153. doi: 10.1016/j.breast.2018.01.002 Abstract BACKGROUND & METHODSThe prospective 'screening with tomosynthesis or...
Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project
Di Stefano F, Giorgi Rossi P, Carozzi F, Ronco G, Cacciani L, Vecchi S, Naldoni C, Segnan N; Gruppo di lavoro MIDDIR – HPV test in primary screening Epidemiol Prev. 2017 Jan-Feb;41(2):116-124. doi: 10.19191/EP17.2.P116.031. Abstract OBJECTIVESTo obtain data on...
Residual fibre lung burden among patients with pleural mesothelioma who have been occupationally exposed to asbestos
Merler E, Somigliana A, Girardi P, Barbieri PG. Occup Environ Med. 2017;74(3):218-227. Abstract OBJECTIVESTo evaluate the lungs asbestos fibres concentration in participants with malignant pleural mesothelioma (MPM) who have been occupationally exposed. METHODSThe...
Time trend in mesothelioma and lung cancer risk in asbestos workers in Italy
Magnani C, Ancona L, Baldassarre A, Bressan V, Cena T, Chellini E, Cuccaro F, Ferrante D, Legittimo P, Luberto F, Marinaccio A, Mattioli S, Menegozzo S, Merler E, Miligi L, Mirabelli D, Musti M, Oddone E, Pavone V, Perticaroli P, Pettinari A, Pirastu R, Ranucci A,...
Increased risk of mesothelioma and lung cancer among workers exposed to asbestos who could require an anticipated retirement
Merler E, Girardi P, Panato C, Bressan V. Epidemiol Prev. 2016;40(1 Suppl 1):26-34. Abstract OBJECTIVESTo assess the association among malignant pleural mesothelioma (MPM) and lung cancer (LC) among workers who have been exposed to asbestos and have or not have...
Confirmation of an excess of cancer mortality in a cohort of workers of a chromium thin-layer plating
Girardi P, Bressan V, Mabilia T, Merler E. Epidemiol Prev. 2015;39(3):183-7. Abstract OBJECTIVESTo extend up to year 2013 the follow-up for mortality of a cohort of workers in a chromium and nickel plating plant, where an excess of lung cancers was already...
The negative impact of tobacco smoking on survival after prostate cancer diagnosis
Polesel J, Gini A, Dal Maso L, Stocco C, Birri S, Taborelli M, Serraino D, Zucchetto A. Cancer Causes Control. 2015 Sep;26(9):1299-305. doi: 10.1007/s10552-015-0624-2. Epub 2015 Jul 2. Abstract PURPOSETobacco smoking has been found to increase prostate cancer (PCa)...
Colorectal Cancer Screening of Immigrants to Italy. Figures from the 2013 National Survey
Turrin A, Zorzi M, Giorgi Rossi P, Senore C, Campari C, Fedato C, Naldoni C, Anghinoni E, Carrozzi G, Bianchi PS, Zappa M; Italian colorectal cancer screening survey group. Prev Med. 2015 Dec;81:132-7. doi: 10.1016/j.ypmed.2015.08.016. Epub 2015 Sep 7. Abstract...
Management of women at high risk of hereditary breast cancer in the Veneto Regional Program for Prevention
Del Sole A, Cinquetti S, Fedato C, Montagna M, Russo F, Sbrogi LG, Zorzi M. Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):99-101. Abstract INTRODUCTIONToday it is well-known that high risk of genetic breast cancer concerns a very limited part of the population: no more...
Comparison between different colon cleansing products for screening colonoscopy. A noninferiority trial in population-based screening programs in Italy
Turrin A, Zorzi M, Giorgi Rossi P, Senore C, Campari C, Fedato C, Naldoni C, Anghinoni E, Carrozzi G, Bianchi PS, Zappa M; Italian colorectal cancer screening survey group. Endoscopy. 2016 Mar;48(3):223-31. doi: 10.1055/s-0035-1569574. Epub 2016 Jan 13. Abstract...
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
Minicozzi P, Innos K, Sánchez MJ, Trama A, Walsh PM, Marcos-Gragera R, Dimitrova N, Botta L, Visser O, Rossi S, Tavilla A, Sant M; EUROCARE-5 Working Group. Eur J Cancer. 2017 Oct;84:335-353. doi: 10.1016/j.ejca.2017.07.015. Abstract BACKGROUNDCancer registries...
Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
Guzzinati S., Virdone S., De Angelis R., Panato C., Buzzoni C., Capocaccia R., Francisci S., Gigli A., Zorzi M., Tagliabue G., Serraino D., Falcini F., Casella C., Russo A.G., Stracci F., Caruso B., Michiara M., Caiazzo A.L., Castaing M., Ferretti S., Mangone L.,...
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Allemani C., Matsuda T., Di Carlo V., Harewood R., Matz M., Nikšić M., Bonaventure A., Valkov M., Johnson C.J., Estève J., Ogunbiyi O.J., Azevedo G. e S., Chen Wan-Qing, Eser S., Engholm G., Stiller C.A., Monnereau A., Woods R.R., Visser O., Hsiang Lim G., Aitken J.,...
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP;...
Geographical variability in survival of European children with central nervous system tumours
Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sánchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowski S, Botta L, EUROCARE-5 Working Group Eur J Cancer. 2017 Sep;82:137-148. doi: 10.1016/j.ejca.2017.05.028. Epub 2017 Jul 6. Abstract Survival for...
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE–5-a population-based study
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE-5 Working Group Lancet Oncol. 2014 Jan;15(1):23-34. doi:...
HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2
Del Mistro A, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Girlando S, Rizzolo R, Frayle H, Trevisan M, Sani C, Burroni E, Giorgi Rossi P, Cuzick J, Ronco G, NTCC Working Group Int J Cancer. 2018 Feb 17. doi: 10.1002/ijc.31326 Abstract HPV testing is more...
Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening
Caumo F, Romanucci G, Hunter K, Zorzi M, Brunelli S, Macaskill P, Houssami N. Breast Cancer Res Treat. 2018 Mar 20 Abstract BACKGROUNDThe Verona population-based breast cancer (BC) screening program provides biennial mammography to women aged 50-69 years. Based on...
Survival of cancer patients in Italy
Coviello V, Buzzoni C, Fusco M, Barchielli A, Cuccaro F, De Angelis R, Giacomin A, Luminari S, Randi G, Mangone L, AIRTUM Working Group Epidemiol Prev. 2017 Mar-Apr;41(2S1):1-244. doi: 10.19191/EP17.2S1.P001.017. Abstract OBJECTIVESPopulation-based survival...
Italian cancer figures – Report 2015: The burden of rare cancers in Italy
Busco S, Buzzoni C, Mallone S, Trama A, Tognazzo S; AIRTUM Working Group Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. Abstract OBJECTIVESThis collaborative study, based on data collected by the network of Italian Cancer Registries (AIRTUM), describes the burden...
Italy 2015: 3 million Italians are living after a cancer diagnosis, both incidence and mortality are decreasing
Dal Maso L, Buzzoni C, Guzzinati S, Crocetti E; AIRTUM Working Group Epidemiol Prev. 2016 Jan-Feb;40(1). Abstract Nella popolazione italiana è stato stimato che nel 2010 vi fossero circa 2.600.000 persone in vita dopo una diagnosi di tumore. Si può ipotizzare che...
Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program
Maggino T, Sciarrone R, Murer B, Dei Rossi MR, Fedato C, Maran M, Lorio M, Soldà M, Zago F, Rossi PG, Zorzi M Br J Cancer. 2016 Aug 23;115(5):525-32. doi: 10.1038/bjc.2016.216. Epub 2016 Aug 4. Abstract BACKGROUNDHPV DNA-based screening is more effective than a Pap...
Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms
Ronco G, Zappa M, Franceschi S, Tunesi S, Caprioglio A, Confortini M, Del Mistro A, Carozzi F, Segnan N, Zorzi M, Giorgi-Rossi P; Italian HPV Survey Working Group Eur J Cancer. 2016 Nov;68:148-155. doi: 10.1016/j.ejca.2016.09.008. Epub 2016 Oct 15. Abstract...
Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy)
Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, de Pretis G, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex DK, Zappa M, Hassan C; Equipe Working Group Gut. 2016 Feb 19. pii: gutjnl-2015-310587. doi: 10.1136/gutjnl-2015-310587. ...
Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment
Rugge M, Genta RM, Graham DY, Di Mario F, Vaz Coelho LG, Kim N, Malfertheiner P, Sugano K, Tsukanov V, Correa P. Gut. 2016 May;65(5):721-5. doi: 10.1136/gutjnl-2015-310846. Abstract CONCLUSIONThe biological, diagnostic and therapeutic panorama has dramatically...
Dietary inflammatory index and prostate cancer survival
Zucchetto A, Gini A, Shivappa N, Hbert JR, Stocco C, Dal Maso L, Birri S, Serraino D, Polesel J. Int J Cancer. 2016 Dec 1;139(11):2398-404. doi: 10.1002/ijc.30208. Epub 2016 Jun 11. AbstractSystemic inflammatory status has been reported to impact survival of...
Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: results from EUROCARE-5
Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, Holleczek B, Johnston BT, Cook MB, Bannon F, Sant M; Eurocare-5 Working Group. Eur J Cancer. 2015 Oct;51(15):2144-2157. doi: 10.1016/j.ejca.2015.07.026. Epub 2015 Sep 26. Abstract BACKGROUNDEuropean...
Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: results of EUROCARE-5
Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, Sant M, Trama A, Faivre J; EUROCARE-5 Workin Group. Eur J Cancer. 2015 Oct;51(15):2169-2178. doi: 10.1016/j.ejca.2015.07.034. Epub 2015 Sep 26. Abstract BACKGROUNDThe EUROCARE study collects and...
Appropriateness of endoscopic surveillance in organized screening programmes based on the faecal immunochemical test
Zorzi M, Senore C, Turrin A, Mantellini P, Visioli CB, Naldoni C, Sassoli De' Bianchi P, Fedato C, Anghinoni E, Zappa M, Hassan C; Italian colorectal cancer screening survey group. Gut 2015 2015 Aug 21. pii: gutjnl-2015-310139. Abstract OBJECTIVESTo assess the...
The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure
Marinaccio A, Corfiati M, Binazzi A, Di Marzio D, Scarselli A, Ferrante P, Bonafede M, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Mazzoleni G, Merler E, Girardi P, Negro C, D'Agostin F, Romanelli A, Chellini E, Silvestri S, Pascucci C, Calisti R,...
Problems, solutions and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa)
Bucchi L, Frigerio A, Zorzi M, Fedato C, et al. Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):52-7. Abstract In this position paper, a self-convened team of experts from the Italian Group for Mammography Screening (Gruppo italiano screening mammografico, GISMa) pointed...
Cancer incidence in children and young adults living in industrially contaminated sites: from the Italian experience to the development of an international surveillance system
Iavarone I, Buzzoni C, Stoppa G, Steliarova-Foucher E; SENTIERI-AIRTUM Working Group. Epidemiol Prev. 2018 Sep-Dec;42(5-6S1):76-85. doi: 10.19191/EP18.5-6.S1.P076.090. Abstract BACKGROUNDthis paper is based upon work from COST Action ICSHNet. Children's...
Mesothelioma Registry: areas of activity
The Regional registry of Mesotheliomas collects cases with a diagnosis of malignant mesothelioma The main activities of the register are: 1) Acquisition and processing of information sources on new mesothelioma diagnoses, such as pathological reports, mortality. 2)...
Attività del Registro Mesoteliomi
L’attività svolta in Veneto ha permesso di calcolare l’incidenza e ricostruire le occasioni di esposizione ad amianto per i casi di mesotelioma insorti nei residenti del Veneto a partire dal 1987. Le principali attività del registro possono essere così sintetizzate:...
Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): A population-based study of individual data for 89828 children from 198 registries in 53 countries
Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Pieros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C; CONCORD Working Group. Lancet Haematol. 2017 Apr 11. Abstract Bonaventure A,...
Fruit and vegetables consumption is directly associated to survival after prostate cancer
Saraggi D, Taborelli M, Polesel J, Parpinel M, Stocco C, Birri S, Serraino D, Zucchetto A. Mol Nutr Food Res. 2017 Apr;61(4). doi: 10.1002/mnfr.201600816. AbstractSCOPESince the evidence on the role of diet on prostate cancer (PCa) prognosis is still...
Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5
Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larraaga N, Colonna M, Agius D, Ardanaz E, Rubi-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group Eur J Cancer. 2017 May;77:140-152....
Gastric Cancer as Preventable Disease
Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY. Clin Gastroenterol Hepatol. 2017 May 19. pii: S1542-3565(17)30602-X. doi: 10.1016/j.cgh.2017.05.023. Abstract Gastric cancer, 1 of the 5...
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients
Rugge M, Meggio A, Pravadelli C, Barbareschi M, Fassan M, Gentilini M, Zorzi M, Pretis G, Graham DY, Genta RM. Gut. 2018 Jan 6. pii: gutjnl-2017-314600. doi: 10.1136/gutjnl-2017-314600. Abstract OBJECTIVEOperative link on gastritis assessment (OLGA) staging for...
Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test
Zorzi M, Hassan C, Capodaglio G, Fedato C, Montaguti A, Turrin A, Rosano A, Monetti D, Stocco C, Baracco S, Russo F, Repici A, Rugge M. Gut. 2017 Nov 3. pii: gutjnl-2017-314753. doi: 10.1136/gutjnl-2017-314753 Abstract BACKGROUNDThe long-term performance of...
Digital Breast Tomosynthesis with Synthesized Two-Dimensional Images versus Full-Field Digital Mammography for Population Screening: Outcomes from the Verona Screening Program
Caumo F, Zorzi M, Brunelli S, Romanucci G, Rella R, Cugola L, Bricolo P, Fedato C, Montemezzi S, Houssami N. Radiology. 2017 Dec 13:170745. doi: 10.1148/radiol.2017170745 Abstract PURPOSETo examine the outcomes of a breast cancer screening program based on digital...
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; & the CONCORD Working Group. Gynecol Oncol. 2017 Feb;144(2):405-413. Abstract OBJECTIVEOvarian cancers comprise several histologically distinct tumour groups with widely different prognosis....
Worldwide comparison of ovarian cancer survival: histological group and stage at diagnosis (CONCORD-2)
Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group. Gynecol Oncol. 2017 Feb;144(2):396-404. Abstract OBJECTIVEOvarian cancer comprises several histological groups with widely differing levels of survival. We aimed to explore...
The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas?
Boscolo-Rizzo P., Zorzi M., Del Mistro A., Da Mosto M.C., Tirelli G., Buzzoni C., Rugge M., Polesel J., Guzzinati S., the AIRTUM Working Group PLoS ONE , published in February 7, 2018 https://doi.org/10.1371/journal.pone.0192621 Abstract The current study aimed to...
Interval Cancers in Colorectal Cancer Screening Programs
Zorzi M., Capodaglio G., Rugge M. Journals Plos, published in February 7, 2018 https://doi.org/10.1371/journal.pone.0192621 Abstract We read with great interest the paper by Van der Vlugt et al. The interval colorectal cancers (I-CRCs) detected in subjects after...
Advanced breast cancer rates in the epoch of service screening: the 400,000 women cohort study from Italy
Puliti D, Bucchi L, Mancini S, Paci E, Baracco S, Campari C, Canuti D, Cirilli C, Collina N, Conti GM, Di Felice E, Falcini F, Michiara M, Negri R, Ravaioli A, Sassoli De' Bianchi P, Serafini M, Zorzi M, Caldarella A, Cataliotti L, Zappa M; IMPACT COHORT Working Group...
An estimate of the number of people in Italy living after a childhood cancer
Francisci S, Guzzinati S, Dal Maso L, Sacerdote C, Buzzoni C, Gigli A; AIRTUM Working Group Int J Cancer. 2017 Jun 1;140(11):2444-2450. doi: 10.1002/ijc.30665. Epub 2017 Mar 11. Abstract Cancers diagnosed in children below the age of 15 years represent 1.2% of all...
In-hospital mortality, 30-day readmission, and length of hospital stay after surgery for primary colorectal cancer: a national population-based study
Pucciarelli S, Zorzi M, Gennaro N, Gagliardi G, Restivo A, Saugo M, Barina A, Rugge M, Zuin M, Maretto I, Nitti D. Eur J Surg Oncol. 2017 Jul;43(7):1312-1323. doi: 10.1016/j.ejso.2017.03.003. Epub 2017 Mar 16. Abstract INTRODUCTIONThe simultaneous assessment of...
Tumori, nel 2020 le persone vive dopo una diagnosi saranno il +37% in più rispetto al 2010
Nel 2020 gli italiani che vivranno dopo aver affrontato una diagnosi di tumore saranno 3,6 milioni, il 37% in più rispetto al 2010. Il dato è contenuto nello studio coordinato dall'Istituto Nazionale Tumori CRO di Aviano in collaborazione con Regione Veneto,...
GRELL Ascension Meeting. Trento 16-18 Maggio 2018
Il GRELL è un gruppo di lavoro che riunisce professionisti dei Registri Tumori e dell'epidemiologia dei tumori dei Paesi di lingua latina, per lo più europei. Maggiori informazioni al sito https://www.grell-network.org
Riduzione della mortalità per tumore alla mammella: pubblicato il nuovo studio sullo screening mammografico in Tumori Journals
Sono stati pubblicati nella rivista scientifica internazionale “Tumori Journals” i risultati di uno studio condotto in collaborazione tra il Registro Tumori del Veneto, il Servizio Epidemiologico Regionale ed il Coordinamento Regionale Screening Oncologici, che hanno...
GRELL Ascension Meeting. 16 – 18 May 2018, Trento – ITALY
Group for Cancer Epidemiology and Registration in Latin Language Countries. More information on https://www.grell-network.org
Monografie
Prostata Incidenza del tumore della prostata. Periodo 2004-2006. Andamenti temporali dal 1990 Mammella Epidemiologia del tumore della mammella in Veneto REGISTRO TUMORI VENETO Epidemiologia del tumore della mammella nelle donne giovani in Veneto. Periodo 2005-2008...
Tumours, in 2020 people living after cancer diagnosis will be 37% more than 2010
In 2020 the number of Italians living after cancer diagnosis will be 3.6 million, 37% more than 2010.This result is presented in the study, coordinated by Aviano National Cancer Institute IRCCS, in collaboration with the Veneto Region, Istituto Superiore di Sanità...
The new Veneto Tumour Registry Website is online
The new Veneto Tumour Registry website is now online: thanks to it, all the Registry data heritage is available to whom is interested (Citizens, Health Authority, scientific Research). The website publishes the epidemiological tumour data of the Veneto inhabitants,...
Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy
Giorgi Rossi P, Carretta E, Mangone L, Baracco S, Serraino D, Zorzi M J Med Screen. 2017 Jan 1:969141316686391. doi: 10.1177/0969141316686391. Abstract OBJECTIVE In Italy, colorectal screening programmes using the faecal immunochemical test from ages 50 to 69 every...
Caratteristiche dei tumori del colon retto nei primi anni 2000: dati dallo studio Impatto dello screening colorettale
Zorzi M., IMPATTO COLONRETTO working group XIX Riunione scientifica annuale AIRTUM Catania, 13-15 aprile 2015 Abstract OBIETTIVIL’impatto dei programmi di screening colorettale si evidenzia solo a diversi anni di distanza dall’attivazione dei programmi. Abbiamo...
Valutazione dell’impatto dello screening mammografico sulla mortalitá per tumore alla mammella
Capodaglio G., Zorzi M., Fedeli U., Bovo E., Guzzinati S., Russo F., Corti M. C., Rugge M. XLI Convegno AIE Mantova, 25-27 ottobre 2017 Abstract INTRODUZIONEIn Veneto i programmi di screening mammografico sono stati avviati nelle prime ULSS a partire dal 1999, e nel...
Esito clinico delle lesioni CIN2 trattate
Frayle H., Del Mistro A., Matteucci M., Insacco E., Onnis G., Rizzi M., Gori S., Nardelli G.B., Zorzi M., Minucci D. Congresso nazionale GISCI 2017 Ferrara, 15-16 giugno 2017 Abstract OBIETTIVIValutare l’esito clinico a breve e medio termine di lesioni CIN2...
Impatto sull’incidenza e la mortalità per cancro del colon retto del programma di screening colorettale nell’ULSS 4 “AltoVicentino”
Dal Zotto A., Banovich F., Bassan F., Borin G., Rigon S., Toffanin R., Guzzinati S., Zorzi M., Fedeli U. XXXIX Congresso AIE 2015 Milano, 28-30 ottobre 2015 Abstract INTRODUZIONEE’ stato dimostrato che i programmi di screening colorettale riducono sia l’incidenza...
Aderenza ai protocolli di follow-up dopo trattamento chirurgico di carcinoma mammario
Guzzinati S., Zorzi M., Tognazzo S., Stocco C., Baracco S., Rosano A., Monetti D., Greco A., Orvieto E., Rugge M. XX Riunione scientifica annuale AIRTUM Reggio Emilia, 13-15 aprile 2016 Abstract OBIETTIVIQuesto studio valuta l’aderenza al follow-up post-chirurgico...
Impatto dello screening mammografico sulla mortalità per tumore della mammella in Veneto
Zorzi M., Fedeli U., Bovo E., Greco A., Monetti D., Rosano A., Stocco C., Capodaglio G., Russo F., Rugge M. XXI Riunione scientifica annuale AIRTUM Catanzaro, 5-7 aprile 2017 Abstract OBIETTIVOValutare l’impatto sulla mortalità causa-specifica dei primi programmi...
Nuove Tecnologie per il cancro della Cervice 2 (NTCC2): disegno dello studio e andamento del reclutamento
Benevolo M., Giorgi Rossi P., Ronco G., Gillio-Tos A., De Marco L., Ghiringhello B., Allia E., Passamonti B., Gustinucci D., Carozzi F., Iossa A., Anderson K., Confortini M., Bisanzi S., Penon G., Bertozzi A., Barbareschi M., Barca A., Quadrino F., Del Mistro A.,...
Tumore maligno del testicolo: validazione dei dati da SDO e recenti trend temporali
Bovo E., Guzzinati S., Zorzi M., Dei Tos A. P., Schievano E., Fedeli U., Saugo M. XXXIX Congresso AIE 2015 Milano, 28-30 ottobre 2015 Abstract INTRODUZIONEI dati dei Registri Tumori indicano un aumento dell’incidenza del tumore maligno del testicolo in Italia....
Studio Impatto dello screening colorettale: analisi della cure fraction
Zorzi M., Baracco S., Guzzinati S., Rugge M. e “Studio Impatto” Working Group XXI Riunione scientifica annuale AIRTUM Catanzaro, 5-7 aprile 2017 Abstract OBIETTIVIDiversi bias causano una sovrastima della sopravvivenza dei tumori screen detected (SD): lead time,...
Impatto dei programmi di screening sull’incidenza per stadio del cancro del colon retto in Italia: risultati studio IMPATTO
Mancuso P., Vicentini M., Carretta E., Mangone L., Zorzi M., Giorgi Rossi P. e “Studio Impatto” Working Group Congresso Nazionale GISCoR 2017 Cremona, 7- 8 novembre 2017 Abstract OBIETTIVIValutare l’impatto dello screening colorettale sull’incidenza per stadio alla...
Tomosintesi vs mammografia in screening: valutazione delle caratteristiche radiologiche e patologiche dei tumori
Rella R., Romanucci G., Zorzi M., Brunelli S., Bricolo P., Cugola L, Caumo F. Convegno Nazionale GISMa Verona, 24-26 maggio 2017 Abstract OBIETTIVIConfrontare le caratteristiche radiologiche e patologiche dei tumori rilevati con tomosintesi mammaria+2D sintetica...
Aderenza ai protocolli di follow-up nei pazienti con diagnosi di tumore del colon retto
Zorzi M., Guzzinati S., Tognazzo S., Bovo E., Rizzato S., Fiore A., Dal Cin A., Baracco M., Rugge M. XX Riunione scientifica annuale AIRTUM Reggio Emilia, 13-15 aprile 2016 Abstract OBIETTIVIQuesto studio valuta l’aderenza al follow-up post-chirurgico dei pazienti...
Studio pilota sul non trattamento immediato delle lesioni CIN2
Del Mistro A., Matteucci M., Frayle H., Rizzi M., Insacco E., Onnis G.L., Gori S., Nardelli G. B., Zorzi M., Minucci D. Convegno nazionale GISCi 2017 Ferrara, 15-16 giugno 2017 Abstract OBIETTIVIValutare il tasso di regressione di lesioni CIN2 non trattate alla...
Aderenza ai protocolli di follow-up dopo trattamento chirurgico di carcinoma mammario
Zorzi M., Guzzinati S., Tognazzo S., Fedato C., Orvieto E., Rugge M. Convegno Nazionale GISMa Finalborgo (Savona), 19-20 maggio 2016 Abstract OBIETTIVIQuesto studio valuta l’aderenza al follow-up post-chirurgico delle pazienti operate per carcinoma infiltrante della...
Compliance with protocols of follow-up among patients with colorectal cancer
Zorzi M., Guzzinati S., Tognazzo S., Rugge M. 7° Congresso triennale di Anatomia Patologica SIAPEC-IAP Genova, 23-26 novembre 2016 Abstract INTRODUCTIONColorectal cancer (CRC) screening programmes exclude from invitation the patients who have been diagnosed with a...
Incidenza e distribuzione per stadio del cancro del colon-retto dopo l’avvio dello screening. Risultati studio IMPATTO
Vicentini M., Mancuso P., Carretta E., Mangone L., Zorzi M., Giorgi Rossi P., “Studio Impatto” Working Group. XXI Riunione scientifica annuale AIRTUM Catanzaro, 5-7 aprile 2017 Abstract INTRODUZIONEL'aumento della sopravvivenza in Italia dal 51% del 1990-1992 al...
Analisi delle complicanze della colonscopia nei programmi di screening colorettale del Veneto
Benazzato L., Fantin A., Fedato C., Guzzinati S., Zorzi M. Congresso Nazionale GISCoR 2017 Cremona, 7- 8 novembre 2017 Abstract OBIETTIVIDefinire il tasso di complicanze e di mortalità a 30 giorni dall’esecuzione della colonscopia nell’ambito dei programmi di...
I trend di incidenza dei tumori del colon-retto nei primi anni 2000 in Italia: i risultati dello studio Impatto
Mangone L., IMPATTO COLONRETTO working group XIX Riunione scientifica annuale AIRTUM Catania, 13-15 aprile 2015 Abstract OBIETTIVI In Italia la mortalità per tumori del colon-retto è in calo dai primi anni ’90 mentre l’incidenza è in aumento (ITACAN). Lo stadio...
Increasing trends in the incidence of potentially human papillomavirus-associated head neck cancer in italy (1988-2012)
Boscolo-Rizzo P., Zorzi M., Del Mistro A., Da Mosto M.C., Rugge M., Polesel J., Guzzinati S. EUROGIN Amsterdam, 8-11 ottobre 2017 Abstract BACKGROUND/OBJECTIVE High risk alpha human papillomaviruses (HPVs) are recognized to be causally related to a subset of head...
Increasing trends in the incidence of potentially human papillomavirus-associated head neck cancer in italy (1988-2012)
Boscolo-Rizzo P., Zorzi M., Del Mistro A., Da Mosto M.C., Rugge M., Polesel J., Guzzinati S. EUROGIN Amsterdam, 8-11 october 2017 Abstract BACKGROUND/OBJECTIVE High risk alpha human papillomaviruses (HPVs) are recognized to be causally related to a subset of head...
Indicators of long-term survival and cure of cancer
Guzzinati S., Dal Maso L., De Angelis R. IACR conference Marrakech, 19-21 ottobre 2016 Abstract BACKGROUNDPresently the indicators of long term survival and cure are lacking.The purpose of this work is to provide estimates of these indicators for 50 cancer types....
Indicators of long-term survival and cure of cancer
Guzzinati S., Dal Maso L., De Angelis R. IACR conference Marrakech, 19-21 october 2016 Abstract BACKGROUNDPresently the indicators of long term survival and cure are lacking.The purpose of this work is to provide estimates of these indicators for 50 cancer types....
Indicators of long-term survival and cure of cancer
Dal Maso L., Guzzinati S., De Angelis R. IARC conference Lion, 7-10 giugno 2016 Abstract PURPOSE: To provide estimates of indicators of long-term survival and cure for 50 cancer types, presently lacking. METHODS Data from 1.6 million Italian cancer patients,...
Indicators of long-term survival and cure of cancer
Dal Maso L., Guzzinati S., De Angelis R. IARC conference Lion, 7-10 june 2016 Abstract PURPOSE: To provide estimates of indicators of long-term survival and cure for 50 cancer types, presently lacking. METHODS Data from 1.6 million Italian cancer patients,...
Patterns of care and cost profiles of cancer patients in Italy: the EPICOST study
Gigli A., Francisci S., Guzzinati S., Busco S., Capodaglio G., Pierannunzio D., Tavilla A., Mallone S., Lopez T. 38° Conferenza annuale IACR Marrakech, 19-21 ottobre 2016 Abstract BACKGROUNDIn most countries cancer accounts for a major proportion of national health...
Patterns of care and cost profiles of cancer patients in Italy: the EPICOST study
Gigli A., Francisci S., Guzzinati S., Busco S., Capodaglio G., Pierannunzio D., Tavilla A., Mallone S., Lopez T. The 38th Annual IACR Conference Marrakech, 19-21 october 2016 Abstract: BACKGROUNDIn most countries cancer accounts for a major proportion of national...
Epicost tool: uno strumento informatico al servizio dei registri tumori
Tavilla A., Francisci S., Mallone S., Pierannunzio D., Gigli A., Lopez T., Capodaglio G., Guzzinati S., Dupaquier V., Ferrari G. XXI Riunione scientifica annuale AIRTUM Catanzaro, 5-7 aprile 2017 Abstract OBIETTIVIIn Italia continua a crescere il numero di pazienti...
Epicost tool: a web-based tool for italian cancer registries
Francisci S., Mallone S., Pierannunzio D., Tavilla A., Gigli A., Lopez T., Capodaglio G., Guzzinati S., Dupaquier V., Ferrari G. GRELL, Ascension Meeting 2017 Bruxelles, 24-26 maggio 2017 Abstract OBJECTIVESIn Italy the number of cancer patients and the economic...
Epicost tool: a web-based tool for italian cancer registries
Francisci S., Mallone S., Pierannunzio D., Tavilla A., Gigli A., Lopez T., Capodaglio G., Guzzinati S., Dupaquier V., Ferrari G. GRELL, Ascension Meeting 2017 Bruxelles, 24-26 may 2017 Abstract: OBJECTIVESIn Italy the number of cancer patients and the economic...
I pazienti lungo sopravviventi per neoplasie in età pediatrica
Francisci S., Alessi D., Buzzoni C., Guzzinati S., Pierannunzio D., Rossi S., Sacerdote C., Tavilla A. XX Riunione scientifica annuale AIRTUM Reggio Emilia, 13-15 aprile 2016 Abstract OBIETTIVIObiettivo generale dello studio è valutare fattibilità e rilevanza di un...
Stime di prevalenza in italia della popolazione adulta con diagnosi di tumore in età infantile
Gigli A., Francisci S., Guzzinati S., Dal Maso L., Buzzoni C. XX Riunione scientifica annuale AIRTUM Reggio Emilia, 13-15 aprile 2016 Abstract OBIETTIVI Stimare il numero di persone che vivono dopo una diagnosi di tumore in età infantile (0-14 anni) in Italia a...
Estimating cancer costs by using cancer registry and administrative data at individual level
Francisci S., Gigli A., Guzzinati S., Busco S., Pierannunzio D., Mallone S. Riunione GRELL Albi (Francia), 4-6 maggio 2016 Abstract OBJECTIVESTo reconstruct cancer pathway and cost-related dynamic according to 3 phases of care: initial, continuing and final....
Estimating cancer costs by using cancer registry and administrative data at individual level
Francisci S., Gigli A., Guzzinati S., Busco S., Pierannunzio D., Mallone S. GRELL Conference Albi (France), 4-6 may 2016 Abstract OBJECTIVESTo reconstruct cancer pathway and cost-related dynamic according to 3 phases of care: initial, continuing and final....
Cost of cancer treatment
Francisci S., Gigli A., Guzzinati S. Conferenza iHEA Milano, 12-15 luglio 2015 Abstract INTRODUCION In most developed countries, cancer accounts for a major and increasing proportion of national health care expenditures. Measuring the burden of disease is of great...
L’impatto economico dei tumori sui sistemi sanitari regionali: stime e proiezioni per diversi scenari di intervento
Gigli A., Francisci S., Pierannunzio D., Guzzinati S., Birri S., Busco S., gruppo di lavoro EPICOST XIX Riunione scientifica annuale AIRTUM Catania, 13-15 aprile 2015 Abstract OBIETTIVI In Italia continua a crescere il numero di pazienti oncologici e il loro...
Patterns of care and cost profiles of cancer patients in Italy: the EPICOST study
Francisci S., Busco S., Capodaglio G., Dal Maso L., Gigli A., Guzzinati S., Mallone S., Piano Mortari A., Pierannunzio D., Tavilla A. ENCR Scientific Meeting and General Assembly Baveno, 5-7 ottobre 2016 Abstract BACKGROUNDIn most countries cancer accounts for a...
Territorial extension of the Veneto Tumour Registry and data usability in the new web portal
Guzzinati S., Bovo E., Bianconi F., Mogini D., Rizzato S., Monetti D., Rosano A., Stocco C., Zorzi M., Rugge M. GRELL Ascension Meeting Trento, 16 -18 may 2018 Abstract OBJECTIVES Over the years the population covered by Veneto Tumour Registry (RTV) has gradually...
Spatial assessment of incidence risk: comparison between MCMC and INLA methodologies in Bayesian hierarchical models
Bovo E., Girardi P., Guzzinati S., Baracco M., Dal Cin A., Carpin E., Memo L., Martin G., Fiore A., Rugge M. GRELL Ascension Meeting Trento, 16 -18 may 2018 Abstract OBJECTIVESLaplace approximation methods as INLA (Integrated Nested Laplace Approximation) are being...
Divergent long-term detection rates of proximal and distal advanced neoplasia in fecal immunochemical test screening programs. A retrospective cohort study
Zorzi M., Hassan C., Capodaglio G., Narne E., Turrin A., Baracco M., et al. Ann Intern Med. 2018. [Epub ahead of print]. doi:10.7326/M18-0855. Abstract BACKGROUND Short-term studies have reported that the fecal immunochemical test (FIT) is less accurate in...
High resolution registry of melanoma and care pathways monitoring in the Veneto Region, Italy
Guzzinati S., Zorzi M., Rossi CR., Buja A., Italiano I., Fiore AR., Dal Cin A., Baracco M., Martin G., Rugge M. ENCR scientific meeting Copenaghen, 26-28 september 2018 Abstract AIMIn 2016 the Veneto Region issued the care pathways for patients with melanoma. The...
Analisi dei cancri intervallo in una coorte sottoposta a più round di screening colorettale
Zorzi M, Stocco C, Baracco S, Chinellato E, Zamberlan S, Monetti D, Rosano A, Greco A, Bovo E, Rugge M. XXIII Riunione scientifica AIRTUM 2019 Trapani, 27-29 marzo 2019 Abstract INTRODUZIONEI programmi di screening del tumore del colon-retto (CCR) che utilizzano il...
Trend di incidenza del tumore del colon retto nei 40-49enni: dati dei Registri Tumori del Nord Est
Zorzi M, Guzzinati S, Mazzoleni G, Piffer S, Serraino D, Dal Maso L, Rugge M. XXIII Riunione scientifica AIRTUM 2019 Trapani, 27-29 marzo 2019 Abstract INTRODUZIONEL’American Cancer Society ha recentemente modificato le proprie raccomandazioni sullo screening...
A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study
Zorzi M, Frayle H, Rizzi M, Fedato C, Rugge M, Penon MG, Bertazzo A, Callegaro S, Campagnolo M, Ortu F, Del Mistro A; Veneto HPV-screening Working Group. BJOG. 2017 Jan 24. doi: 10.1111/1471-0528.14575. AbstractOBJECTIVETo compare the results from an initial...
Indicators for monitoring screening programs with primary hpv test
Zorzi M, Giorgi Rossi P; Gruppo di lavoro sugli Indicatori dello screening con test HPV primario Epidemiol Prev. 2017 Jan-Feb;41(1):1-32 doi: 10.19191/EP17.1S1.P001.001. Abstract BACKGROUNDFollowing scientific evidence produced in numerous studies, as well as...
Trends in net survival from cervical cancer in six European Latin countries: results from the SUDCAN population-based study
Haelens A, Roche L, Bastos J, Woronoff AS, Zorzi M, Francart J; GRELL EUROCARE-5 Working Group. Eur J Cancer Prev. 2017 Jan;26:S92-S99. AbstractCancer survival is a key measure of the effectiveness of a healthcare system. As differences in healthcare systems are...
Quality assurance in melanoma care: The EU-MELACARE study
Sommariva A., Forsea AM., Agius D., Ascierto PA., Bastiaannet E., Borgognoni L., Demetriou A., Garbe C., Gavric Z., Hocevar M., Innos K., Larønningen S., Louwman M., Robsahm TE., Rutkwoski P., van Akkooi A., Zorzi M., Pasquali S., van de Velde C., Rossi CR. Eur J Surg...
Statement of Mesoteliomi Registry
National levelDecree of the President of the Council of Ministers (DPCM) no. 308 dated 10 December, 2002 establishing the “Regulations for the definition of the model and the procedures for keeping the register of asbestos-related mesothelioma cases”. The national...
Normativa del Registro Mesoteliomi
Livello NazionaleIl DPCM n. 308 del 2002 ha istituito il Registro nazionale dei casi di mesotelioma asbesto-correlati presso l’ISPESL (ora INAIL). Nel registro sono raccolte le informazioni relative ai casi di mesotelioma della pleura, del peritoneo, del pericardio e...
Mesothelioma Registry Methods
The Regional Operating Centre (COR) of the Veneto Region is located at the Epidemiological Department - Azienda Zero in Padova and it collaborates with the Local Health Units’ Services for Prevention, Hygiene and Safety in the Workplace (SPISAL). The Mesothelioma...
Metodi Registro Mesoteliomi
Il Centro Operativo Regionale (COR) del Veneto è situato presso la UOC Servizio Epidemiologico Regionale e Registri (SERR) di Azienda Zero e, in collaborazione con i Servizi di Prevenzione Igiene Sicurezza Ambienti di Lavoro (SPISAL), ha il compito di identificare i...
Introduction of Mesoteliomi Registry
Introduzione Mesoteliomi
Il Registro ha il compito di identificare tutti i casi di mesotelioma incidenti in Veneto e di analizzare la storia professionale, residenziale e ambientale dei soggetti ammalati.
Methods
Presentazione
Il Direttore Scientifico presenta il Registro Tumori del Veneto (RTV) Desidero dare il benvenuto ai visitatori del Registro Tumori del Veneto e offrire qualche informazione generale sul profilo organizzativo di questa Istituzione della Sanità Regionale. Il testo è...
Links
Regione Veneto Sistema Epidemiologico Regione del Veneto Rete Oncologica Veneta Associazione italiana dei registri tumori International Association of Cancer Registries European Network of Cancer Registries International Agency for Research on Cancer World Health...
Links
Regione Veneto Sistema Epidemiologico Regione del Veneto Rete Oncologica Veneta Associazione italiana dei registri tumori International Association of Cancer Registries European Network of Cancer Registries International Agency for Research on Cancer World Health...
Mappa contatti
Registro Tumori della Regione Veneto {google_map}passaggio Gaudenzio, 1 35131 Padova PD|width:100%|height:400|link:yes|link_full:yes{/google_map} Registro Tumori Veneto
Contacts map
Veneto Tumour Registry {google_map}passaggio Gaudenzio, 1 35131 Padova PD|width:100%|height:400|link:yes|link_full:yes{/google_map}
Tumore della testa e del collo
Epidemiologia dei tumori testa-collo in VenetoStefano GuzzinatiRegistro Tumori del Veneto (RTV)Servizio Epidemiologico Regionale (SER)Padova, 23 maggio 2016 Epidemiologia del tumore della testa e del collo.pdfDownload
Population and area
List of Veneto "Aziende ULSS" and Hospitals Population covered: 4.880.936 (100%) AZIENDA ULSS 1 DOLOMITI AZIENDA ULSS 2 MARCA TREVIGIANA AZIENDA ULSS 3 SERENISSIMA AZIENDA ULSS 4 VENETO ORIENTALE AZIENDA ULSS 5 POLESANA AZIENDA ULSS 6 EUGANEA AZIENDA ULSS 7...
Territorio e Popolazione
Elenco delle Aziende ULSS e Ospedaliere del Veneto Popolazione coperta: 4.879.133 (100%) AZIENDA ULSS 1 DOLOMITI AZIENDA ULSS 2 MARCA TREVIGIANA AZIENDA ULSS 3 SERENISSIMA AZIENDA ULSS 4 VENETO ORIENTALE AZIENDA ULSS 5 POLESANA AZIENDA ULSS 6 EUGANEA AZIENDA ULSS 7...
Cards
Normativa Regionale
Informazioni sul trattamento di dati personali ai sensi e per gli effetti dell'art 13 e 14 del Regolamento (UE) 2016/679 Regolamento 3/2013 del 12 agosto 2013, “Norme per il funzionamento del Registro Tumori del Veneto (RTV), istituito con Legge Regionale 16 febbraio...
Statement
Dati del Veneto
I dati relativi alle principali neoplasie in Veneto aggiornati al 2020. Sono presenti statistiche relative all’incidenza, alla sopravvivenza e alla prevalenza dei tumori per sede neoplastica, sesso e fasce di età. Incidenza Sopravvivenza Prevalenza Calcolo...
Dati per ULSS
Dati di incidenza suddivisi per Aziende ULSS. Dati complessivi di incidenza, trend temporali, confronto tra ULSS, dati di incidenza relativi alle principali patologie tumorali. Disponibili i dati relativi all'anno 2020. ULSS 1 Dolomiti I Incidenza: Tutti i tumori...
Dati per sede
Dati di incidenza per le principali neoplasie. Confronto per sesso e fasce di età, trend di incidenza, confronto tra Aziende ULSS, rischio cumulativo. Sedi tumorali: mammella, prostata, colon retto, polmone, stomaco, rene e vie urinarie, tiroide, melanoma, vescica,...
Pubblicazioni scientifiche
Pubblicazioni scientifiche del Registro Tumori Veneto.
Monografie
Report per sede tumorale e monografie
Congressi e conferenze
Comunicazioni orali e poster
Research publications
Research publications of Veneto Tumour Registry.
Meenting and conferences
Oral communications and posters.
Monographs
Reports by tumour site and monographs.
Veneto Data
Updated data to 2018 on the main neoplasms in the Veneto region. Incidence, survival and prevalence statistics of tumours by site, gender and age groups. Incidence data Survival data Prevalence data Dynamic calculation of epidemiological...
Tumour site data
Incidence data for the main neoplasms. Comparison by gender and age group, incidence trend, comparison among ULSS, cumulative risk. Tumour sites: breast, prostate, colon rectum, lung, stomach, kidney and urinary tract, thyroid, melanoma, bladder, cervix and corpus...
ULSS data
Incidence data by ULSS. Overall incidence, incidence trend, comparison between ULSS, incidence by main tumour site. Data for 2018 is available. ULSS 1 Dolomiti I Incidenza: Tutti i tumori Sedi: Prostata, Mammella, Colon retto e ano, Polmone, Stomaco, Rene e vie...
Monografie per sede
Monografie relative alle principali sedi tumorali. Prostata Incidenza del tumore della prostata. Periodo 2004-2006. Andamenti temporali dal 1990 Mesoteliomi Report Mesoteliomi. Marzo 2018 Mammella Epidemiologia del tumore della mammella in Veneto. Periodo 1990-2019...
Monografie per età
Monografie per fasce di età. I tumori nei bambini e negli adolescenti in Veneto. Periodo 2014-2018 e andamenti temporali dal 1990. I tumori nei bambini e negli adolescenti in Veneto. Periodo 2009-2013 e andamenti temporali dal 1990. I tumori nei bambini e negli...
Monografie per area
Monografie per area geografica. Stime 2023 per ULSS Stime del numero di casi incidenti in Veneto nel 2023 per ULSS ULSS 1 Dolomiti ULSS 1 Dolomiti - Tassi di incidenza 2013 ASL 1 Belluno - Analisi dell'incidenza dei tumori 1990-2002 ASL 2 Feltre - Analisi...
Registro Tumori del Veneto
Il Registro Tumori del Veneto (RTV) è stato formalmente istituito con la Legge Regionale n. 11 del 16 febbraio 2010. Le norme del Regolamento Regionale sono state pubblicate nel 2013 le “Norme per il funzionamento del Registro Tumori del Veneto”, così come approvate...